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Quinone methides (QMs) generated in vivo can alkylate DNA and function as 
anti-cancer drugs.  Delivery of QMs to target DNA is necessary to reduce the side 
effects caused by indiscriminate reaction.  Previous, DNA was conjugated with a 
QM and was successfully used to deliver this QM to complementary DNA sequences.  
Peptide nucleic acids (PNAs) conjugates of QM are now being developed for in vivo 
application since PNA binds to its complementary DNA or RNA and PNA resists 
degradation by nucleases and proteases.  
 The PNA1-QMP1 conjugate is capable of alkylating more than 60% of a 
complementary ssDNA when added at nearly stoichiometric quantities.  No 
alkylation was observed if non-complementary DNA was treated with the conjugate.  
PNA1-QMP1 can alkylate a non-complementary DNA only when both the PNA and 
DNA target bind to a template strand.  When no target sequences were present in 
solution, QM can react with nucleophiles from PNA1 and generate PNA1-QM1 self 
  
adduct.  ssDNA can be alkylated by PNA1-QM1 self adduct with a 40% yield.  
The self adduct can survive after an incubation for 7 days in aqueous solution and 
preserve half of its original ability to alkylate complementary DNA.  The 
reversibility and stability of the self adduct suggest that it can be used in cells.  
ssRNA can also be recognized and modified by PNA conjugates with a similar yield 
as earlier demonstrated with ssDNA.  A PNA1-QM1 self adduct may also function 
as a telomerase inhibitor by alkylating RNA within telomerase. 
      Polypyrimidine PNAs were prepared to bind to the major groove of duplex 
DNA selectively and expand the potential targets from single to double strand DNA.  
A cytosine-rich PNA recognized dsDNA and delivered an electron-rich QMP2 to its 
target sequences.  The polypurine strand within a target dsDNA was alkylated at 
37°C with a yield of 26%.  PAN-QMP2 also showed strong selectivity toward its 
fully matched dsDNA over one base mismatch in the triplex recognition site.  
Successful delivery of a QMP to target single and double strand DNA by PNAs 
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Chapter 1 Introduction 
1.1 Importance of DNA alkylation. 
Deoxyribonucleic acid (DNA) is the hereditary material used by almost all 
organisms.1  The genetic information is stored in the different sequences composed 
of four bases: adenine, thymine, guanine and cytosine (Scheme 1.1).  The bases are 
connected to 2’-deoxyribose sugars and linked by a phosphodiester backbone.  Most 
DNA exists in a duplex form.  Two strands of complementary DNA form a double 
helix structure in an anti-parallel manner. 
 
Scheme 1.1 Structures of DNA bases adenine, thymine, guanine and cytosine 
DNA can be damaged by different mutagens like alkylation agents, oxidizing 
agents and radiation.  The rate of DNA damage is 103 to 106 molecular lesions per 
cell per day.2  While this accounts for less than 0.0002% of all human genome, the 
DNA damage at some genes may cause severe diseases like cancer.  However, 
modification of DNA in cancer cells may inhibit their replication and help to cure the 




to some natural products like duocarmycin A and mitomycin C can alkylate DNA 
(Scheme 1.2).  
 
Scheme 1.2 DNA alkylation agents 
Although the structures of alkylation agents and the DNA adducts are different, 
there are mainly three types of DNA alkylation – mono-alkylation, intrastrand 
crosslink and interstrand crosslink.  Alkylation agents can react with one single 
nucleophile from DNA and generate a mono-adduct (Scheme 1.3).  Some agents 
like mitomycin C can alkylate two different nucleophiles from DNA to generate intra- 
and interstrand DNA adducts.  Among the three types of DNA adducts, interstrand 
is the most potent because the crosslink may inhibit the replication of dsDNA.3 
 





1.2 Reversible and irreversible DNA alkylation agents. 
Alkylation agents react with most nucleophiles of DNA. There are both 
reversible and irreversible DNA alkylation products.  Irreversible DNA alkylation 
induced by compounds like methyl iodide and dimethylsulfate causes permanent 
DNA damage.  These compounds react with most of the nucleophiles of DNA 
through an SN2 mechanism.   Methyl iodide reacts at the O
6 and N7 positions of dG, 
N1 and N7 positions of dA, N3, N4 and O2 positions of dC.4  Dimethylsulfate reacts 
with dG N7, dA N1 N3 and dC N3 primarily.4  The high activity toward DNA and 
volatile property make these compounds extreme hazardous.  
Besides irreversible mono-DNA alkylation, some chemotherapeutic agents such 
as platinum compounds (Scheme 1.4) and mitomycin C can also induce irreversible 
DNA cross-link adducts.   
 
Scheme 1.4 Structures of platinum drugs 
Cisplatin is first hydrolyzed, replacing one chloride by a water molecule, the 
intermediate is then subjected to attack from DNA nucleophiles. It is found that the 
N7 position of dG is the primary alkylation site.5  Cisplatin can continue to 
hydrolyze and alkylate another strand of DNA.  The generated interstrand DNA 
cross-link can ultimately trigger apoptosis. 
Although widely used as an anti-cancer drug, cisplatin also causes side effects 




generation carboplatin yields the same active component as cisplatin inside cells but 
hydrolyze at a much slower rate and reduce the side effects in some patients. To 
improve the selectivity of platinum compounds toward DNA in tumor cells, cisplatin 
was conjugated to directing agents like oligonucleotides and acridines.7, 8  These 
conjugates increase the sequence selectivity and should reduce off target modification 
in cells.  The effect of directing agents will be discussed in detail later in this 
chapter. 
Mitomycin C (1.5) belongs to a family of aziridine-containing natural products 
and is used as a chemotherapy agent because of its ability to form DNA cross-link 
(Scheme 1.5).9  Its modification of DNA is dependent on reductive bioactivation to 
form 2,7-diaminomitosene (1.6), a type of quinone methide, as the major intermediate.  
The mono-adduct 1.7 can continue to eliminate a carbamate and generate a second 
electrophile center.  Intermediate 1.8 can then be attacked by another nuclophile 
from DNA and form a bis-DNA cross-link adduct.  Many solid tumors are lack of 
oxygen comparing to normal cells.  Since mitomycin C is activated by reduction, 
mitomycin C is more likely to be activated in tumor cells while inhibited by an 
oxygen-rich environment.  Mitomycin C irreversibly alkylates DNA like methyl 
iodide and dimethylsulfate, but mitomycin C selectively binds to the minor groove of 
DNA and almost exclusively alkylates DNA at the N2 position of guanine. To further 
increase the target selectivity and defeat drug resistance, mitomycin C was conjugated 



















































Scheme 1.5 Generation of DNA adduct from mitomycin C via QM 
 
While most of DNA adducts are irreversible, some potent DNA alkylation 
agents can generate reversible DNA adducts.  Leinamycin is a DNA-damaging agent 
which shows significant antitumor activity (Scheme 1.6).11  Leinamycin is first 
activated by thiol in vivo12 to form an intermediate that mainly alkylates the N7 
position of guanine.12  The guanine N7 adduct is reversible and can either regenerate 
an episulfonium ion or be quenched by water.  The reversible reaction has the ability 
to escape trapping with non-target sequences and prolong the life of the active 
intermediate.  Because there are high concentrations of thiols like glutathione and 





























































Scheme 1.6 Alkylation of DNA by leinamycin 
 
1.3 Quinone Methides (QMs) 
The Rokita group used a class of DNA alkylation agents - quinone methides 
(QMs) to systematically study their reactivity toward various nucleophiles of DNA 
and the reversibility of each DNA adduct.  QMs are electrophilic intermediates that 
can be generated in vivo and react with nucleophiles such as amines, water and thiols 
(Scheme 1.7).13-17  A nucleophile attacks the exocyclic methylene group and 
regenerates the phenol moiety.  There are two major types of QMs: o-QM and p-QM.  
Both o-QM and p-QM have resonance structures that contain both anionic and 
cationic centers.  The polarized nature of QMs indicate that they can react with both 






Scheme 1.7 Structure of quinone methide and its adductive product 
 
Generally, QMs are very reactive in aqueous solution and their lifetimes range 
from 1 ms to several minutes depending on their substituents.18-21  In contrast, some 
natural diterpene and triterpene QMs found in plant are stable and persist for days or 
even months (Scheme 1.8).22  Diterpene shows a strong tumor suppress effect in rats. 
Triterpene also exhibits high cytotoxicity in a panel of cancer cell lines including 
human lung carcinoma A-549 and colon carcinoma HT-28.23 
 
 





QMs are usually prepared by the activation of qunione methide precursors 
(QMPs) in situ (Scheme 1.9).  QMs can be generated from thermal methods,24 UV 
light,25-27 oxidation by Ag2O and PbO2,
28, 29 and biological methods.30-32  
 
Scheme 1.9 Generation of QMs 
   
Several groups studied the generation of QM by oxidation and generation of 
interstrand cross-linking by QM.33-35  Greenberg group incorporated a phenyl 
selenide modified nucleotide into a sequence of DNA.34  After a complementary 
DNA was annealed with the DNA containing modified nucleotide, NaIO4 or light was 
used to activate phenyl selenide moiety and generate QM (Scheme 1.10).  Since the 
modified nucleotide is incorporated into a sequence, only nucleophiles from its 




incorporation renders a selectivity toward nucleophiles near to the QM and reduces 
random alkylation.   
 
Scheme 1.10 Interstrand cross-linking by phenyl selenide derivatives  
 
Generation of QM intermediates by fluoride offers a method to prepare QM with 
almost quantitative yield within hours.36-38  The hydroxyl group is protected by silyl 
ether and a good leaving group (X = bromide or acetate) is linked to the benzylic 
position.  The generation of QM is triggered by adding fluoride.  The generated 
QM intermediate can be attacked by nucleophiles from DNA to form DNA alkylation 
products. When there are two leaving groups, QMs can react with two nucleophiles 
from either the same strand or different strands of DNA (Scheme 1.11). 
 




1.4 Reversibility of nucleoside-QM adducts 
QM intermediate can react with different nucleophiles from DNA and form both 
reversible and irreversible DNA adducts.39  The Rokita group found that strong 
nucleophiles from DNA (dG N7, dC N3 and dA N1) form adducts with QM quickly 
but the adducts are reversible.  These kinetic products can regenerate QM.  An 
oligonucleotide-QM self adduct persists reversibility over at least 8 days in aqueous 
buffer and can regenerate QM intermediate.  In contrast, the lifetime of QM itself is 
millisecond to second.   
 
Scheme 1.12 Structures of reversible (blue) and irreversible (black) DNA-QM 
adducts 
 
The generation and stability of different deoxynucleoside adducts were used to 
study time-dependent alkylation of deoxynucleosides by an unsubstituted ortho-QM 
(Scheme 1.12).39  dA N1 and dC N3 were the major adducts in the first 10 hours. 




of dC N3 adduct remained in solution.  dG N2, dG N1 and dA N6 generated 
irreversible adducts with QM.39  The thermodynamic adducts accumulated over time. 
Eventually, irreversible products dominate in the solution. The kinetic adducts of dA 
N1, dC N3 and dG N7 can serve as QM reservoirs for the regeneration of the highly 
transient QM intermediate (Figure 1.1).  
 
Figure 1.1 Time-dependent evolution of deoxynucleoside alkylation by a quinone 
methide (copied from ref 39).  
 
Rokita group used a bisQMP-acridine conjugate to generate DNA cross-linking 
and study the reversibility of DNA adducts (Scheme 1.13).40, 41  Since there are two 
acetate leaving groups on benzyl ring, the bisQMP can generate two QM intermediate 
and ultimately alkylate two nucleophiles from DNA.  The ratio of DNA 
cross-linking to mono-alkylation by bisQMP-acridine was much greater than the ratio 
of cross-linking to mono-alkylation induced by N-mustard.42, 43  The difference 
between the two alkylation agents can be rationalized by the reversibility of QM.  




reversible dG N7-QM adduct could continually be captured by other nucleophiles 
from DNA.  On contrary, N-mustards generate irreversible adducts and avoids 
further nucleophiles of other strand to attack the N-mustard and form DNA 
crosslinking.44 
 
Scheme 1.13 bisQMP-acridine conjugate 
 
Rokita group also used the mixture of deoxynucleosides (dA, dT, dG and dC) 
and bisQMP-acridine to study which was the best at extending the lifetime of QM 
(Figure 1.2).  Interestingly, only dA extends the life time of QM for more than 
100-fold by measuring its ability to generate DNA cross-linking.40  A single strand 
DNA containing dA was even more effective in preserving the activity of bisQM than 
dA.  After the single strand DNA was incubated with bisQMP-acridine for 24 hours, 
incubation with additional 1000-fold excess of 2-mercaptoethanol for 72 hours only 
suppressed 50% of bisQM’s alkylation ability.  The result showed that once formed, 
the regenerated QM from reversible dA-N1-bisQM adducts still prefer the 




dA-bisQM adducts effectively extend the lifetime of short-lived QM intermediate and 
improve the alkylation yield of bisQMP. 
 
 
Figure 1.2 Extending the life time of bisQMP by generating dA-bisQM reversible 
adducts (copied from ref 40). The blue template represents a acridine intercalator. 
   
1.5 Substituent effect on the stability of QM 
 Substituents on aromatic ring of QM also influence the stability of QM adducts 
and alter the kinetics and reactivity of QM reaction with nucleophiles of DNA.45  
Since QM intermediates are typically electron deficit, electron-donating groups will 
stabilize the intermediate and electon-withdrawing group will destabilize the 
intermediate.  Rokita group used a QM which has substituents on aromatic ring to 





Figure 1.3 Substituent effect on the generation of dC N3-QM adducts (copied from 
ref45) 
When there is no substitution on the aromatic ring, formation of the dC N3-QM 
adduct reached a maximum yield after around 10 hours.  When an electron-donating 
methyl substituent was added (X = Me), the dC N3-MeQM adduct formed much 
quicker than its unsubstituted analogue QM (~ 2 h vs 10 h).  Since the 
electron-donating methyl group stabilizes the QM intermediate, the QM was quickly 
re-generated and could be quenched by other nucleophiles like water.  Twenty five 
hours later, less than 10% of initial dC N3-MeQM adduct was found by HPLC.  
When X = COOEt, the re-generation of QM is slow and the dC N3-QM adduct 
slowly accumulated even after 50 hours since the electron-withdrawing methyl ester 
destabilize the QM intermediate.  By fine tune the substituents on the aromatic ring, 





1.6 Target delivery of QMP by various agents 
     Many chemotherapeutic agents inhibit the replication of cancer cells by 
alkylating DNA.  The lack of selectivity of alkylating agents toward DNA sequences 
limits the use of DNA alkylation in clinical.  Many cellular components like protein 
and water as well as non-target DNA can also compete with target DNA and react 
with active QM intermediate.  To reduce side reactions, alkylating agents such as 
N-mustard, psoralen and QM precursors conjugated with site directing ligands have 
been deployed with great success to alkylate target DNA and induce DNA 
cross-linking.46-52  Site directing agents can bind with target sequences by hydrogen 
bonding, van der Waals or hydrophobic forces.53-56  DNA alkylating agents are 
co-localized with the target sequence and modify nearby DNA bases.   
DNA intercalators which bind to DNA non-covalently are used as one type of 
delivery agents.  DNA intercalators have been used to deliver DNA alkylating 
agents to major groove of duplex DNA.40, 57  Rokita group prepared a 
bisQMP-acridine conjugate for DNA cross-linking.  BisQM directed by acridine can 
react with guanine N7 specifically since guanine N7, which is one of the strongest 
nucleophiles of DNA locates in the major groove of DNA.  Acridine effectively 
improves the DNA binding affinity.  Conjugation of the bisQMP with acridine 
significantly increased its cross-linking efficiency by over 50-fold than bisQMP 
itself.42  
Although acridine can direct DNA alkylating agents to DNA, it is not sequence 
specific.  To deliver a DNA alkylation agent to a target sequence, oligonucleotides 




DNA.  Directing agents can be easily prepared and have high fidelity toward their 
complementary sequence.  The Rokita group used ssDNA-QMP conjugate to study 
the target delivery of QMP (Scheme 1.14).37  A ssDNA-QM self-adduct can be 
formed in the absence of target sequences.  The self adduct is reversible and still 
alkylates target DNA even after eight days pre-incubation in aqueous solution.  
Meanwhile, non-complementary DNA is neither alkylated by the DNA-QM self 
adduct nor did it interfere with alkylation of the target sequence.  Recognition and 
alkylation of target sequences make the conjugates of ODNs and DNA alkylation 
agents a useful strategy in target delivery.  The modification of target DNA by 
reversible self-adduct avoids the use of toxic fluoride and makes the system 
potentially useful in a cell environment.37 
 
 
Scheme 1.14 Selective delivery of QMP by DNA sequence 
     DNA triple helix (triplex) structures are also used to direct DNA alkylating 
agents to their targets.  Triplex forming oligonucleotides (TFOs) bind to polypurine 




polypurine strand, it binds to dsDNA in an anti-parallel manner while a 
polypyrimidine TFO attaches to dsDNA in a parallel manner (Scheme 1.15).  
    
Scheme 1.15 Formation of DNA triplex 
    Polypyrimidine or polypurine DNA sequences as TFOs have been studied by 
several groups to deliver DNA alkylation agents like psoralen,59, 60 transplatin61, 62 and 
QMP63 to target sequences.  Psoralen-TFO generated site-specific mutations within 
mammalian cells by forming DNA crosslinking.60  Platinum-modified TFO can 
form a stable triplex structure and generate DNA deoxyguanines or deoxyadenines 
adducts that are adjunct to the TFO binding site.  
The Rokita group conjugated a bisQMP with a polypyrimidine TFO and studied 
its alkylation of duplex DNA (Figure 1.4).63  Approximate 20% of the purine-rich 
strand was alkylated while only around 4% for the pyrimidine-rich strand. The 
difference may indicate that the nuclophiles from the purine-rich strand are more 





Figure 1.4 Triplex recognition and selective alkylation (from ref63) 
    DNA as a directing agent limits its use in vivo since DNA can’t pass through the 
cell membrane.  The lability of DNA toward DNase makes it difficult to be 
deployed in vivo.  Oligosaccharides can permeate cell and have been used to 
interfere with transcription.64, 65  Still, the lack of broad DNA sequences recognition 
makes carbohydrates a poor candidate to selectively deliver DNA alkylation agents.  
Pyrrole-imidazole polyamides which are inspired by natural distamycin represent a 
class of small molecules which can bind to selected DNA sequences as well as pass 





Scheme 1.16 Structure of distamycin, a pyrrole-imidazole polyamide and Py, Im, Hp 
      Distamycin contains three N-methylpyrrole (Py) amino acids and binds to the 
minor groove of DNA at A, T tracts.72  Py, N-methyllimidazole (Im) and 
N-methyl-3-hydroxypyrrole (Hp) were linked by amide bonds to recognize bases of 
DNA.  Py/Im targets C/G bases pair and Py/Hp targets A/T.73  By carefully 
following the pairing rules, a Py-Im sequence can selectively bind with any 
predetermined DNA sequences.  Several DNA alkylating agents such as seco-CBI,71 
chlorambucil70 and bisQMP49 have been conjugated with polyamides. 
Polyamide-seco-CBI alkylated adenine adjacent to the binding site at a nanomolar 
concentration.71  Both chlorambucil and bisQMP conjugates also showed alkylation 
near the polyamide binding sites.  However, reaction at the predicted recognition 
sequence by bisQMP-polyamide conjugates was low (4%).49  Generation of 
bisQM-polyamide self adduct within one hour was confirmed by HPLC and mass 




irreversibility of bisQM-polyamide self adduct.  The reversibility of self adducts is 
key to their regeneration and prolonged the life time of QM.  Since the self adduct is 
irreversible, only the initially generated QM can possibly alkylate target DNA 
sequence.  Once the bisQM self adduct is formed, QM can no longer be transferred 
to DNA.  
     Since both DNA and polyamide have their limitations for use in vivo, new site 
directing agents which can penetrate the cell membrane, selectively bind to target 
DNA, remain stable inside of cells and generate the reversible QM self adducts are 
necessary.  
 
1.7 Peptide nucleic acids (PNAs) as delivery agents 
PNA is a DNA mimic with repeating N-(2-aminoethyl)-glycine units as the 
polymer backbone.  A, T, G and C bases are linked onto backbone via a methylene 
carbonyl groups (Figure 1.5).74  PNA can bind with complementary DNA or RNA 
by Watson-Crick bases pairing.  Unlike DNA, PNAs are shown to resist nucleases 
and proteases in vivo and capable of inhibiting translation in vivo.75  Since PNA has 
the same bases as DNA, it is reasonable to expect that PNA-QM self adducts should 





Figure 1.5 Structures of DNA and PNA 
 
PNA can avoid many limitations caused by DNA or polyamides when used in 
vivo.  Complementary PNA/DNA binds tighter than a comparable DNA/DNA 
duplex due to the lack of charge repulsion between the two sequences since the 
backbone of PNA is neutral.  Single base mismatches in PNA/DNA duplex are more 
destabilized than equivalent one in DNA/DNA.75 
Although most of oligonucleotides exist as a duplex in cells, single-stranded 
oligonucleotide such as a messenger RNA is available in cells.  Single-stranded 
oligonucleotide can be a good alkylation target.  Mixed bases PNA can recognize its 
complementary DNA and deliver alkylation agents.  But the delivery of those 
alkylation agents to duplex DNA is problematic.  A mixed-bases PNA sequence 
does not show any dsDNA invasion ability alone unless the recognition site sits at the 




A polypyrimidine sequence of PNA was first designed to recognize duplex 
DNA by forming a PNA/DNA2 triplex (Figure 1.5).
75, 77  Unexpectedly, after the 
PNA bound to the major groove of dsDNA, PNA invaded into dsDNA and generated 
triplex invasion structure.77  The PNA/DNA/PNA sandwich structure leaves the 
polypurine ssDNA in the solution (triplex invasion in Figure 1.5).  Nielsen showed 
that three to five positive charged at the end of a PNA sequence can aid the 
generation of triplex and triplex invasion.74  The extra charges also increases the 
solubility of PNA and improve its cellular uptake.78  Triplex invasion is found to be 
affected by salt concentration.  High salt concentration will suppress triplex invasion 
since the melting point of dsDNA increases with higher salt concentration.  It is 
always necessary to take the salt concentration in consideration when PNA is used to 
form triplex or triplex invasion structures. 
Both a N-mustard79 and a psoralen80 have been conjugated to a polypyrimidine 
PNA to investigate the delivery of these DNA modification agents to target DNA by 
PNA.  DNA alkylation were found near the PNA binding sites since both triplex and 
triplex invasion were formed.79  Compared to PNA itself, the alkylation stabilizes 
PNA binding in cell and creats a robust method to prevent transcription.  
  Although polypyrimidine PNA can recognize dsDNA, the recognition sites 
are restricted to continuous polypurine/polypyrimidine sequences.  PNA sequences 
which can interact with mixed-bases dsDNA is useful to deliver DNA alkylation 
agents to any sequences.  For this reason, pseudo-complementary PNAs (pcPNAs) – 
diaminopurine (D) and thiouracil (US) were designed and synthesized to replace 




of oxygen by sulfur in US do not interfere with the formation of hydrogen bonds 
between T-D and A-US while there is a steric clash between the amino group in D and 
thiol group in US.  This makes the formation of pcPNA/pcPNA duplex disfavored. 
Only DNA/DNA and pcPNA/DNA can be formed.  
 
 
Scheme 1.17 Interactions between PNA bases A, T and pcPNA bases D, US 
Psoralen was conjugated with pcPNA and was delivered to a target dsDNA 
within plasmid DNA.  Psoralen conjugated with pcPNA induced targeted 
mutagenesis at a mixed sequence with both episomal and chromosomal DNA without 
obvious off-target modification.52, 80, 82  The induced mutations and deletions were at 
the predicted pcPNA binding site.  These data showed that PNA can be useful in 
delivering DNA alkylating agents to target DNA sequences in vivo.  
This dissertation investigates the target alkylation of ssDNA, ssRNA and 




self adducts and their self adducts were characterized.  Formation of PNA triplex 
and triplex invasion to deliver a QM to dsDNA was accomplished.  This study helps 
to understand the target delivery of a QM to pre-selected sequences by PNA, 









Oligonucleotide-quinone methide precursors (QMPs) have demonstrated 
effective alkylation of target DNA, but the lability of oligonucleotides to nucleases 
limits their use in a cell environment.  The inability of oligonucleotides to penetrate 
cell membrane also limits delivery of a QMP to cells.  Peptide nucleic acids (PNAs) 
can bind with their complementary DNA by standard Watson-Crick base pairing and 
should discriminate between matched and mismatched DNA.  PNAs conjugated 
with positively charged amino acids (lysine and arginine) have been shown to pass 
the cell membrane.78, 83, 84  Thus QMP can be delivered to target sequence by 
conjugating with PNAs.  The PNA-QMP conjugate can continue to alkylate target 
sequences in vitro and in vivo.  In this chapter, the alkylation of predetermined 
sequences from oligonucleotides in telomerase by PNA-QMP conjugate and 
PNA-QM self-adduct is studied.  
Telomeres contain a highly repeated DNA structures at the ends of linear 
chromosomes.85  Human telomeres contain about 5-15 kilobases of a tandem repeat 
sequence (5’-TTAGGG-3’) at the end of telomeres.  The sequence provides a 
method for cells to distinguish the natural termini from random breaks.  These 
structures also help to stabilize DNA during replication.86  Telomeres keep 




minimum threshold, the protective telomere caps become destabilized and result in 
replicative senescence or cell death.88  
In some human cell types such as adult germline cells and stem cells, telomere 
length is maintained by telomerase during the proliferation of cells.89  Telomerase is 
an ribonucleoprotein that adds repeating 5’-TTAGGG-3’ to the 3' end of DNA 
strands in the telomere regions.90  In most normal cells, telomerase activity is almost 
undetectable.91  In contrast telomerase activity is found in most human tumors.92  
The length of the telomeres in tumor cells does not continuously shorten with the 
successive cell divisions because of the presence of active telomerase. Telomerase is 
then thought to be an essential factor in the “immortal”93 property of tumor cells 
(Scheme 2.1).  Thereby, telomerase is a potential target for anti-tumor drugs.  
 
Scheme 2.1 Binding of the end of a telomere to human telomerase94 
Oligonucleotide-based therapeutics are potential methods to develop 
anti-cancer drugs by binding to the telomerase.95  There are two major subunits in 
human telomerase: hTERT and hTR.  hTR is a RNA component that acts as a 
template for replication and hTERT is a protein that catalyzes nucleotide 




potential PNA binding sites.  The Corey group synthesized a series of PNA 
oligomers to bind progressively to different sites on the RNA template within 
telomerase.94  Peptide nucleic acid (PNA) can inhibit telomerase activity with an 
IC50 ranges from 30 uM to 0.001 uM depending on the length of PNA and its binding 
site.  A PNA (5’-GTTAGGGTTAG-3’) which binds to nucleotide 45-65 
(5’-CUAACCCUAAC) was found to inhibit telomerase activity with IC50 = 0.01 
uM.94  We decided to use the 11 bases PNA sequence to selectively deliver QMP to 
RNA in telomerase because 11 bases PNA is easy to prepare and renders strong 
binding to RNA in telomerase.  We expect QMP to alkylate RNA in telomerase and 
inhibit the activity of telomerase. 
In this chapter we synthesized and characterized a PNA1-QMP1 conjugate and 
first studied the delivery of QMP1 to DNA which represents the 45-65 bases RNA 
template in telomerase.  After successful recognition of the correct sequence by 
PNA and alkylation of the sequence by QMP, we continued to examine the delivery 
of QMP to target RNA in telomerase by PNA.  Inhibition of telomerase activity was 
also studied by telomeric repeat amplication protocol (TRAP assay). 
 
2.2 Result and Discussion 
2.2.1 Preparation of PNA1 
PNA1 (5’-AEEA-Arg-GTTAGGGTTAG-LeuArgArgAlaSerLeuGly-3’) is 
composed of a 11 base PNA sequence (red), a 7-mer peptide (kemptide) at the 3’ end 
of the PNA and an extra arginine and 8-amino-3,6-dioxaoctanoic acid (AEEA) at the 





Scheme 2.2 Structure of PNA1 
There are several reasons to design the PNA1 sequence: 
a) Kemptide96 is readily phosphorylated by protein kinase A (PKA) at the Ser. 
Thus the 5’-LRRASLG-3’ sequence in PNA1 can function as a 
phosphorylation site in place of the standard 5’-phosphorylation of DNA in 
cell environment where the labeling of DNA sequence is difficult. 
b) We found that the free amine from arginine at the 5’ terminus of PNA 
sequence can not react with QMP1-succinimidyl (NHS) ester and generate 
PNA-QMP1 conjugate.97  The amine group at the 5’ terminus of the PNA 
and QMP1 may be too close to the peptide and PNA backbone and be 
hindered by the possible self folding of PNA.  One AEEA98 attached at the 
5’ terminus of the conjugate elongates the linker containing the free amine 
group and facilitates the conjugate of PNA1 with QMP1. 
c) The use of PNA in vivo is hampered by its poor water solubility. Arginine 
and AEEA improve the solubility of PNA in water. 
PNA1 was prepared by solid phase peptide synthesis (SPPS) following 
previous reported protocols.78, 97, 99  Benzyloxy-carbonyl (Z) protected PNA 
monomers which are commercially available were used in SPPS through the 





Scheme 2.3 Z-protected PNA- A, T, G and C monomers 
The carboxylic acid of a monomer was activated by O-(7-aza-benzotriazol-1-yl) 
-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) and was coupled to the 
free amine groups from the 4-methylbenzhydrylamine (MBHA) resin.  After 15 – 20 
minutes of coupling, the non-reacted starting material and by products were washed 
away by dichloromethane while the added monomer was retained on resin. After 
washing, the t-boc protecting group of the monomer on resin was removed by 
trifluoroacetic acid (TFA).  Another washing step with dichloromethane was 
performed to remove excess of TFA and its byproducts.  The free amine group from 
the first monomer on resin was ready to react with each successive PNA monomers.  
By repeating the coupling, deprotecting and washing procedures, the desired peptide 
and PNA chain was formed on the solid resin.  Finally, the PNA1 chain was 
removed from the resin by treatment with trifluoromethanesulfonic acid (TFMSA).  
The resulting PNA1 was precipitated by cold ethyl ether, further purified by reverse 




2.2.2 Preparation of PNA1-QMP1 and PNA1-QM1 self-adduct  
QMP1-succinimidyl (NHS) ester was synthesized following procedures 
reported before (Scheme 2.4).37, 97  An aqueous solution of the starting material 2.1 
was mixed with 30% HCHO and 10% NaOH, and the final pH was adjusted to 8 by 
NaOH to generated 2.2.  Aqueous solution containing crude 2.2 was adjusted to pH 
2 - 3 by 1M HCl and 2.2 was extracted by ethyl ether.  Then the corresponding acid 
was purified by chromatotron.  The hydroxyl groups of 2.2 were then protected by 
tert-butyldimethylsilyl chloride (TBDMSCl) and imidazole.  After Lewis 
acid-catalyzed replacement of the benzylic TBDMS group with acetate, the product 
2.4 was coupled with N-hydroxysuccinimidyl (NHS).  The final product 
QMP1-NHS was purified by column chromatography and stored at -20°C.  
Previously, the QMP1-NHS ester was thought to hydrolyze slowly to its carboxylic 
acid after a couple of months at -20°C.  Interestingly, 1H NMR shows that even after 






Scheme 2.4 Synthesis of QMP1-NHS ester 
Conjugation of QMP1-NHS ester with PNA1 was achieved as reported 
previously.37, 97  The mixture was purified by C18 RP-HPLC (Scheme 2.5, Figure 
2.1).  The retention time shifted from 15 minutes (PNA1) to 28 minutes 
(PNA1-QMP1).  This is mainly caused from the hydrophobic TBDMS group.  The 
eluent at 28 minutes was collected and confirmed by MALDI as PNA1-QMP1.  
PNA1 calculated (m/z) was 4144.6, MALDI (m/z) found was 4143.3.  When HPLC 
purified PNA1-QMP1 was stored at -20°C for eight months, HPLC showed that more 





Scheme 2.5 Generation of PNA1-QMP1 
 
Figure 2.1 RP-HPLC purification of crude PNA1 (A) and crude PNA1-QMP1 (B) 
linear gradient of 10% to 55% aqueous acetonitrile with 0.1% trifluoroacetic acid 
(TFA) at 1 ml/min over 30 minutes was used to elute the materials. 
 
The PNA1-QM1 self adduct was prepared by incubating HPLC purified 
PNA1-QMP1 with potassium fluoride.  The PNA1-QM self adduct was purified by 
RP-HPLC (Scheme 2.6, Figure 2.2, B).  The mass of self adduct was confirmed by 
MALDI. PNA1-QM1 self adduct calculated (m/z) was 4305.8 and MALDI (m/z) 
found was 4304.7. 
 





Figure 2.2 RP-HPLC of PNA1-QMP1 and its self adduct (A) PNA1-QMP1 was 
stored at -20°C for eight months. The decomposition product is PNA1-QMP1 loss of 
its –TBDMS protecting group; (B) fresh PNA1-QM self-adduct. A linear gradient of 
10% to 55% aqueous acetonitrile with 0.1% trifluoroacetic acid (TFA) at 1 ml/min 
over 30 minutes 
 
 
2.2.3 Alkylation of ssDNA by PNA1-QMP1 
After PNA1-QMP1 was successfully generated, alkylation of ssDNA by 
PNA1-QMP1 was performed to study whether PNA1 can deliver QMP1 to single 
strand target sequence.  A complementary [32P]-OD1 and 1.1 equivalent of 
PNA1-QMP1 was incubated in the presence of fluoride at room temperature and then 
characterized by 20% denaturing gel electrophoresis (Scheme 2.7).  If OD1 is 
alkylated by PNA1-QMP1, PNA1-QM1-[32P]-OD1 could be denatured but will be 
still covalently linked and have a slower electrophoretic mobility than [32P]-OD1.  
The alkylation yield can be calculated by quantifying the radio-activity of 
PNA1-QM1-[32P]-OD1 with the sum of the total radio-activity of DNA adduct and 





Scheme 2.7 Alkylation of DNA by PNA1-QMP1 
A slowly migrating species was found on denaturing gel electrophoresis which 
is consistent with interstrand alkylation (Figure 2.3).  After a 48 hour incubation at 
room temperature, the PNA1-QM1-[32P]-OD1 product accumulated in a first order 
process to yield almost 60%. The rate and yield are equal to that reported previously 
using a DNA-based delivery agent.37  Less than 2.0% of alkylation was discovered 
by gel when a non-complementary DNA (OD5, 5'-CGACTGCAGACT-3') was 
incubated with PNA1-QMP1 (Table 2.2, Figure 2.7, lane 2).  Thus PNA1 can 
deliver QMP1 to its target sequence selectively.  Without the formation of 





Figure 2.3 DNA alkylation by PNA1-QMP1 conjugate. (A) Gel electrophoresis of 
DNA alkylation products. [32P]-OD1 (3.0 μM) was mixed with PNA1-QMP1 (3.3 μM) 
in solution of NaCl (130 mM), MES (130 mM, pH 7.0) and KF (130 mM) for 0 – 8 
days. The products were characterized by 20% polyacrylamide denaturing gel. (B) 
Alkylation of [32P]-OD1 by PNA1-QMP1 was quantified and fit to a first order 
process, t1/2 = 30 h. The error represents the range of two independent determinations. 







2.2.4 Alkylation of DNA by radio labeled PNA1-QMP1 
The ultimate goal of this project is to deploy the PNA1-QM1 self adduct into 
cell environments.  We decided to radio label the PNA1 sequence and [32P]-PNA1 
can function as a marker to help to trace the exact reaction spot in the future in vitro 
and in vivo research.  For our target delivery of QMP1 by PNA1 project, 
[32P]-PNA1-QM1-OD1 should have the same electrophoretic mobility as 
PNA1-QM1-[32P]-OD1.  This can confirm that species moves slower than 
[32P]-OD1 on gel electrophoresis are the DNA adducts we expected. 
Radio-labeling of PNA1-QMP1 by cAMP-dependent protein kinase A (PKA) 
and [32P]-adenosine-5’-triphosphate (ATP) followed a published procedure.100  A 
C18 Sep-Pak cartridge was used to purify [32P]-PNA1-QMP1 by removing buffer and 
ATP.   
Alkylation of target ssDNA was evaluated by incubating complementary OD1 
with [32P]-PNA1-QMP1.  The highest band on gel electrophoresis is labeled 
[32P]-PNA1-QMP1 conjugate since it carries only one charge and barely moves.  
Products of the same electrophoretic mobility were appeared in the middle of gel 
regardless of which oligomer contained the label.  [32P]-labeled PNA1-QMP1 
showed a similar alkylation yield (63% vs 51%) and the alkylation rate of target DNA 
sequence by [32P]-PNA1-QMP1 was comparable to alkylation of [32P]-DNA by 






Figure 2.4 Alkylation of ssDNA by PNA1-QMP1.  Alternative [32P]-labeling of the 
target OD1 and PNA1-QMP1 generates the same product with an intermediate 
electrophoretic mobility.  PNA1-QMP1 (3.3 μM) was incubated with OD1 (3.0μM) 
in solution of NaCl (130 mM), MES (130 mM, pH 7.0) and KF (130 mM) for 0 – 3 
days at room temperature. 
  
 
2.2.5 Discrimination of a single base mismatch in DNA alkylation 
The ultimate utility of the quinone methide conjugate relies on its ability to 
discriminate between target and off-target sequences. A related DNA-QM conjugate 
had previously showed target alkylation of its complementary DNA, but the response 
to a single mismatch between a conjugate and its target had not been examined.  To 
measure the extent of this selectivity, two DNA targets which have one base 
mismatch (OD2, OD3) were prepared (Table 2.1).  OD2 has a T/T mismatch at the 











Table 2.1 Sequences of PNA1-QMP1 conjugate, PNA complementary DNA and 
DNAs with one-base mismatch. The mismatched base is underlined. 
 
 
Figure 2.5 Alkylation of OD1,OD2 and OD3 by PNA1-QMP1. Lane 1: control. 
ssDNA (lane 2, [32P]-OD1 (3.0 μM); lane 3, [32P]-OD2 (3.0 μM); lane 4, [32P]-OD3 
(3.0 μM)) was mixed with PNA1-QMP1 (3.3 μM) in buffer containing NaCl (130 
mM), MES (130 mM, pH 7.0) and KF (130 mM) for 2 days 
 
The PNA1-QMP1 conjugate was still fully capable of alkylating OD2 or OD3 in 
the absence of OD1 as expected since association between OD2 or OD3 and 
PNA1-QMP1 is thermodynamically favored over the alternative of single-stranded 
structures (Figure 2.5).  OD3 and complementary OD1 showed equivalent 
alkylation yield by PNA1-QMP1 while OD2’s alkylation yield is slightly lower than 
OD1.  Although a single mismatch in the middle of OD3 is expected to decrease the 
melting point of PNA1/OD3, the PNA1/OD3 duplex can still form and deliver QMP1 




PNA1/OD2 duplex, QMP1 had higher chances to rotate freely in the solution than 
tightly binding PNA1/OD3 and thus had lower alkylation yield.  
To further address the effect of single base mismatch on target sequence 
alkylation, we incubated different ratios of OD1 and OD2 with PNA1-QMP1 and 
analyzed the target alkylation yield (Figure 2.6).  Alkylation of OD2 decreased by 
70% after addition of one equivalent of OD1 and was essentially blocked after 
addition of 5 equivalents of OD1.  Conversely, one equivalent of OD2 suppressed 
alkylation of OD1 by only 16%, and even 10 equivalent of OD2 only suppressed 
alkylation of OD1 by half.  
 
Figure 2.6 Competition for alkylation by PNA1-QMP1 targets containing no 
mismatches (OD1) and a single mismatch (OD2). Selectivity for [32P]-OD2 was 
measured in the presence of 0 – 10 equivalents of OD1 and 1.2 equivalents of 
PNA1-QMP1. Conversely, the selectivity for [32P]-OD1 was measured in the 
presence of 0 – 10 equivalents of OD2 and 1.2 equivalents of PNA1-QMP1. Reaction 
mixtures were incubated for 192 h in the presence of NaCl (130 mM), MES (130 mM, 






Both the location and type of mismatches formed between the conjugate and its 
target variants may affect the selectivity of alkylation, but the high potential for 
distinguishing between fully and partially complementary sequences is clearly 
apparent from this single example.  The lone T/T mismatch limited alkylation of 
OD2 to 25% of the total reaction of OD1 and OD2 at equimolar concentrations 
(Figure 2.6, lane 3 vs. lane 2).  This level of discrimination is likely higher than that 
expected from a DNA conjugate since mismatches appear to be more destabilizing in 
PNA/DNA than DNA/DNA duplex.75 
 
2.2.6 Template-dependent alkylation of a non-complementary target 
Alkylation of a non-complementary nucleotide sequence by the QMP1 
conjugate will expand the utility of PNA1-QMP1 conjugates.  Previously, it was 
shown that two ssDNA can be assembled via bis-PNA template.101  Because 
unrelated sequences can be co-localized and oriented for reaction by hybridization to 
a template strand, alkylation of a non-complementary target sequence can be achieved 
with a template strand (Scheme 2.8). 
Template OD4 is complementary to PNA1 and has extra 13 free bases which 
serve as the binding site of the third strand of DNA.  A series of DNA sequences 
(OD5 – OD8) that differ in only their 3’-termini can bind to OD4 by Watson-Crick 
pairing.  OD5 – OD8 are non-complementary to PNA1 and serve as PNA1-QMP1 
alkylation targets.  OD5 – OD8 were co-localized with PNA1-QMP1 since both 




OD4 and OD5 – OD8 to identify the requirement for alkylation of OD5 – OD8 
(Table 2.2). 
PNA1-QMP1 3'-GLSARRL -GATTGGGATTG-Arg-AEEA-QMP1-5’ 
OD4 5'-CTAACCCTAAC CAGTCTGCAGTCG-3' 
OD5                           3'-TCAGACGTCAGC-5' 
OD6                          3'-GTCAGACGTCAGC-5' 
OD7                      3'-TTGGTCAGACGTCAGC-5' 
OD8                      3'-GCTGTCAGACGTCAGC-5' 
Table 2.2: Sequences of PNA1-QMP1 conjugate and DNA sequences 
 
Scheme 2.8 Template directed alkylation of a non-complementary target 
 
In the absence of its targets, PNA1-QMP1 merely alkylated the template strand 
OD4 (Figure 2.7, lane 1). When there is no template sequence OD4, no interstrand 
alkylation of any non-complementary sequences OD5 – OD8 occurred (Figure 2.7, 
lane 3 & 4; Figure 2.8, lane 3 & 6). In the presence of the template OD4, only about 
1% of alkylation was observed between PNA1-QMP1 and a target (OD5) that aligned 
one residue away from the conjugate. Less than 2% alkylation was observed for 
another target (OD6) that bound directly adjacent to PNA1-QMP1 (Figure 2.7, lane 5 
& 6). Extending a target strand by three nucleotides (OD7) to overlap and compete 




alkylation (2 - 4%, Figure 2.8, lanes 1 and 2). Only when a target (OD8) contained a 
non-complementary 3 bases extension that remained free to react with the transient 
QM of PNA1-QMP1 can generated ~ 40% DNA alkylation (Figure 2.8, lane 5). 
 
Figure 2.7 Alkylation of OD4, OD5 and OD6 by PNA1-QMP1. [32P]-OD4 (3.0 μM, 
lane 1) and [32P]-OD5 (3.0 μM, lane 2) were incubated with PNA1-QMP1 (3.3 μM) 
in NaCl (130 mM), MES (130 mM, pH 7.0) and KF (130 mM) for 5 days under 
ambient conditions before analysis. [32P]-OD5 (3.0 μM, lane 3) and [32P]-OD6 (3.0 
μM, lane 4) were incubated with PNA1-QMP1 (3.3 μM) under equivalent conditions 
for 2 days prior to analysis. [32P]-OD5 (3.0 μM, lane 4) and [32P]-OD6 (3.0 μM, lane 
6) were incubated with PNA1-QMP1 (3.3 μM) under equivalent conditions for 2 days 
prior to analysis. 
 
The reversibility of QM reaction was also studied by first generating the 
PNA1-QM1-OD4 adduct.  Alkylation of OD4 alone by PNA1-QMP1 produced a 
yield of ~31% (Figure 2.7, lane 1).  This PNA1-QM1-OD4 adduct then served as a 
reservoir of QM since QM transfer was still observed after either target OD7 and 
OD8 was added 192 h subsequent to incubation of PNA1-QMP1, OD4 and fluoride 




conditions was ~ 50% less than that generated when all strands were present at the 
initiation of QM formation. However, the relative reactivity of OD7 versus OD8 
remained unchanged. The decrease in alkylation yield after pre-generation 
PNA1-QM1-OD4 reflects the regeneration of QM and the weakly competing 
reactions of water and weak nucleophiles of DNA.  Whether target reaction derives 
from the initial generation of QM or from subsequent regeneration by reversible DNA 
adducts, a 3 bases single-stranded and non-complementary region adjacent to the 
PNA conjugate gave maximum yields of target alkylation.102 
 
 
Figure 2.8 Template-dependent alkylation of target DNA. PNA1-QMP1 (3.3 μM) 
and the template OD4 (3.0 μM) were incubated for 192 h under ambient conditions in 
MES (130 mM pH 7) and NaCl (130 mM) after reaction was initiated by addition of 
KF (130 mM). OD7 (lane 1) and OD8 (lane 4) were then added to this mixture and 
incubated for another 192 h prior to electrophoretic analysis. Alternatively, 
PNA1-QMP1, OD4 and either OD7 (lane 2) or OD8 (lane 5) were mixed together 
under equivalent conditions prior to addition of KF and incubation for 192 h. 
PNA1-QMP1 and either OD7 (lane 3) or OD8 (lane 6) were also mixed together in 
the absence of the template OD4 under equivalent conditions prior to addition of KF 





2.2.7 Alkylation of ssDNA by a PNA-QM self-adduct 
Alkylation of a target DNA sequence by an oligo-QM self adduct avoids the 
requirement of toxic fluoride to initiate the reaction.  Thus the self adduct could be 
used in vivo without need of an additional trigger.  Previously, the Rokita group 
showed that both a DNA-QM self adduct37 and a pyrrole-imidazole-QM self adduct49 
can be generated, but only DNA-QM self adduct is reversible and can continue to 
alkylate a target sequence.  It is useful to study whether PNA1-QM1 self adduct can 
be generated and alkylate target ssDNA. 
We used RP-HPLC to monitor the generation of PNA1-QM1 self adduct 
(Figure 2.9) and examined the reversibility of the self adduct by its ability to alkylate 
a target sequence.  Upon addition of fluoride, deprotection of the silyl group 
intermediate (DP) was generated and detected at 260 nm on HPLC (Figure 2.9, 0 h).  
After four hours, all the PNA1-QMP1 was converted to DP and the PNA1-QM 
self-adduct. Twelve hours later, only the PNA1-QM1 self adduct was observed.  All 
of these intermediates and final self adducts were collected, lyophilized and 
successfully characterized by MALDI. The formation of self adduct proceeded at a 
rate similar to that observed previously for the generation of DNA-QM self adduct.37  
This shows that the kinetics of oligo-QM self adduct generation is only affected by 
the nucleophiles. At least for PNA and DNA, the backbone does not affect the 





Figure 2.9 Generation of the PNA1-QM1 self adduct. A) PNA1-QMP1 was mixed 
with KF (130 mM) in a solution of NaCl (130 mM), MES (130 mM, pH 7.0). 
Mixtures were analyzed by RP-HPLC after 0 – 32 hours. B) Materials from different 
peaks (0 h: 25 – 27 min was PNA1-QMP1; 4 h, 8 h: 18 – 21min was DP and 
PNA1-QM1 self adduct; 32 h: 18 – 20 min was PNA1-QM1 self adduct)from 




After the generation of PNA1-QM1 self adduct, the delivery of a QM1 to target 
target DNA by PNA1 was examined by incubating the self adduct (1.1 equiv.) 
generated in situ with [32P]-OD1 in buffer at room temperature.  After various time, 
a high molecular weight species corresponding to PNA1-QM1-DNA adducts was 
found on 20% denaturing gel electrophoresis (Scheme 2.9, Figure 2.10).  
Although the interstrand cross-linking induced by the self adduct is slower than 
that induced by PNA1-QMP1 (t1/2 = 30 h vs. t1/2 = 10 h), no chemical signal is needed 
to initiate the alkylation, and this will allow the self adduct to be used in vivo in the 
future.  DNA alkylation by the PNA1-QM self adduct was around 40% after 4 days 
whereas equivalent of PNA1-QMP1 generated > 60% alkylation yield.  The 
difference of alkylation rate is because QM generated from QMP1 within a duplex 
can participate in intra- and interstrand alkylation directly.  In contrast, release of the 
QM from a reversible self adduct may require a structural reorganization of its 
complex before interstrand alkylation may occur.  Meanwhile, all the QMP1 can be 
converted to QM to participate DNA alkylation whereas the PNA-QM self adduct 
contains both reversible and irreversible self adduct. 
 






Figure 2.10 DNA alkylation by PNA1-QM1 self adduct. (A) Gel electrophoresis of 
DNA alkylation products. The self-adduct was prepared in situ by addition of KF 
(130 mM) to a solution PNA1-QMP1 (3.3 μM) in MES (130 mM pH 7) and NaCl 
(130 mM) and incubated under ambient conditions for 24 h.  The target [32P]-OD1 
(3.0 μM) was then added and incubation was continued for the indicated time.  The 
products were characterized by 20% polyacrylamide denaturing gel. (B) Alkylation of 
[32P]-OD1 by PNA1-QM1 self adduct was quantified and fit to a first order process. 
The error represents the average of two independent determinations.  
 
Previously, we showed that PNA1-QMP1 can be radio-labled by PKA and 




2.2.4, Figure 2.4).  We then radio labeled PNA1-QM1 self adduct by PKA and 
[32P]-ATP following the same procedure to prepare [32P]-PNA1-QMP1.  After 
[32P]-PNA1-QM1 self adduct was incubated with OD1 for 8 days, no alkylation of 
OD1 by [32P]-PNA1-QM1 was found on gel (data not shown).  We think that 
reversible PNA1-QM1 self adduct might be converted to irreversible products by 
either nucleophiles from PNA1 itself or from nucleophiles in buffer during the radio 
labeling procedure.  Thus the irreversible [32P]-PNA1-QM1 lost its ability to further 
alkylate target DNA.  
 
2.2.8 Stability of PNA1-QM1 self adduct 
The final yield of target alkylation is affected by the percentage of reversible self 
adduct since the reversible self adduct keeps regenerating QM intermediate and is 
quenching by weak nucleophiles to form irreversible products.39  When 
PNA1-QMP1 was treated with fluoride, intrastrand alkylation of PNA1 by QM1 form 
reversible adducts which are dominate since strong nucleophiles react with QM1 
quicker than weaker nucleophiles..  After longer time incubation, the reversible self 
adducts may slowly redistribute to their irreversible adducts (Scheme 2.10).  Study 
the stability of PNA1-QM1 self adduct will help the understanding of self adduct 






Scheme 2.10 Generation of a QM intermediate from the reversible PNA-QM self 
adduct and its irreversible trapping by water and weak nucleophiles from PNA102 
 
 
Stability of self-adduct in aqueous solution was evaluated by measuring the 
ability of OD1 alkylation by the self-adduct after its pre-incubation in aqueous 
solution for 0 – 7 days (Figure 2.11).  More than 50% of self-adduct’s original 
alkylation ability was maintained (26% vs 44%) after a seven day pre-incubation of 
the PNA1-QM self adduct in aqueous solution at room temperature prior to addition 
of [32P]-OD1.  This means that half of the reversible self adduct was quenched after 
incubation without target sequences.  Meanwhile, still half of the reversible self 
adduct was resistant to quenching and retained its ability to generate a QM 
intermediate and alkylate target DNA.  This is consistent with previous data from 
our group that DNA-QM self adducts retain half of their alkylation ability after 8 days 









Figure 2.11 DNA alkylation by the PNA1-QM1 self adduct. The self adduct was 
prepared in situ by addition of KF (130 mM) to a solution PNA1-QMP1 (3.3 μM) in 
MES (130 mM pH 7) and NaCl (130 mM) and incubated under ambient conditions 
for 24 h.  The self adduct was incubated under the same conditions for additional 0 – 
7 days prior to addition of target [32P]-OD1 (3.0 μM).  Incubation was then 
continued for 8 days and the alkylated product was quantified.  The average of two 
independent determinations was plotted and fitted to a first order process. The error 
represents the range of the observed yields. 
 
Although the exact nucleophiles which quench the QM1 intermediate are 
unclear, we expected irreversible adduct between QM and water contributes to the 
loss of self adduct activity.  Mass spectroscopy showed that even after eight days 
pre-incubation in buffer under room temperature, PNA1-QM1 self adduct remained 





Figure 2.12 MALDI characterization of PNA1-QM1 self adduct after eight days 
incubation. The self adduct (5 μM) was generated by incubation of PNA1-QMP1 in 
solution of NaCl (130 mM), MES (130 mM, pH 7.0) and KF (130 mM) for 24 hours. 
The mixture was incubated at room temperature for an additional 8 days and then 
purified by C18 Sep-Pak cartridge, lyophilized, re-dissolved in water and 
characterized by MALDI. PNA1-QM1 self adduct calculated m/z: 4305.8, found: 
4303.1; PNA1-QM1 water adduct calculated m/z: 4323.8, found: 4321.2 
 
2.2.9 Alkylation of ssRNA by PNA1-QMP1 and PNA1-QM1 self adduct 
  Our ultimate goal is to utilize the PNA1-QM1 self adduct to induce target RNA 
alkylation in telomerase and inhibit the function of telomerase.  Previously, Corey 
group found that a 11 base PNA (5’-GTTAGGGTTAG-3’) can effectively bind to 
RNA in telomerase.94  We studied the target alkylation of ssRNA in vitro before 





Scheme 2.11 Alkylation of ssRNA by PNA1-QMP1 and PNA1-QM1 self adduct.  
 
Unfortunately, the PNA/RNA duplexes could not be denatured by gel 
electrophoresis under the conditions used to denature PNA/DNA duplex.  To 
differentiate covalently linked PNA1-QM1-RNA adduct from PNA1/RNA duplex, 
the duplex need to be denatured.  More formamide was added to help the denaturing 
since formamide can stabilize ssRNA in solution and electrophoresis.  Previously, 3 
µL PNA/DNA sample was mixed with 3 µL formamide before loading onto gel.  In 
the revised procedure, 3 µL PNA/RNA sample was mixed with 7 µL formamide 
before loading onto gel.  After loading, gel was running at 50 - 55°C instead of 40 - 






Figure 2.13 (A) Gel electrophoresis of RNA alkylation by PNA1-QM1 self adduct 
and PNA1-QMP1. [32P]-RNA (3.0 μM) was mixed with PNA1-QM1 self adduct or 
PNA1-QMP1 (3.3 μM) in solution of NaCl (130 mM) and MES (130 mM, pH 7.0) 
for 0 – 72 h. (B) Alkylation of [32P]-RNA by PNA1-QMP1 with fluoride, 
PNA1-QMP1 without fluoride and PNA1-QM1 self adduct were quantified and 






Both PNA1-QMP1 and PNA1-QM1 self adduct could alkylate target RNA.  
The alkylation rate of RNA was quicker than DNA (t1/2 = 2.2 h vs. 10 h), and the 
alkylation yield of RNA by PNA1-QMP1 was ~60% which is similar to the 
alkylation yield of ssDNA.  The alkylation rate of RNA by PNA1-QM1 was also 
found be quicker than alkylation rate of DNA (RNA t1/2 = 8 h vs. DNA t1/2 = 30 h). 
Quicker alkylation of RNA than DNA by PNA1-QMP1 might because of the 
structure of RNA.  Different conformation of PNA1/RNA from PNA1/DNA may 
contribute the fast alkylation of RNA.   
 
2.2.10 Telomeric repeat amplication protocol (TRAP assay) used to monitor the 
inhibition of telomerase activity  
We are interested in inhibiting telomerase activity by alkylation of RNA in 
telomerase with PNA1-QM1 self adduct since the RNA can be recognized and 
modified by reversible PNA1-QM1 self adduct.  We collaborated with Prof. Xiang 
Zhou’s research group (Wuhan University) and used a TRAP assay to test the 
inhibition of telomerase by the PNA1-QM1 self adduct.  There are two steps in a 
TRAP assay.  In the first step, telomerase adds telomeric repeats (GGTTAG) onto 
the 3’ end of the substrate oligonucleotide and generates a series of oligonucleotides 
which are only different by various numbers of telomeric repeats.  In the second step, 
the products are amplified by polymerase chain reaction (PCR) and visualized.  
When telomerase is active, a DNA ladder will appear on gel electrophoresis.  When 
the activity of telomerase is inhibited, the adding of telomeric repeats will stop and a 





Figure 2.14 Characterizing the activity of PNA1 and PNA1-QM1 self adduct toward 
telomerase by TRAP assay (Data from Dan Zhang in Prof. Zhou’s lab).  Different 
amount of PNA1 or PNA1-QM1 self adduct was mixed with telomerase for 0 – 90 
hours before the telomerase was extracted and used in TRAP assay.  The telomerase 
was extracted by phenol/chloroform and used in TRAP assay. For every time point, 
lane 1: negative control (no telomerase was used in step one); lane 2: positive control 
(telomerase was not treated by PNA1 or PNA1-QM1 self adduct and used directly); 
lane 3: PNA1 250 nM; lane 4: PNA1 500 nM; lane 5: PNA1-QM1 self adduct 250 
nM; lane 6: PNA1-QM1 self adduct 500 nM.  
   
When telomerase was pre-treated with PNA1 or PNA1-QM1 self adduct for 0 
hours, telomerase activity did not change from the positive control (Figure 2.14, 0 h, 
lane 3 – 6 vs lane 2).  In all cases, telomerase added telomeric repeats at the end of 
the oligonucleotide.  Neither PNA1 nor the PNA1-QM1 self adduct affect the 
telomerase activity.  After 72 hours pre-incubation of telomerase with PNA1 or self 
adduct, both PNA1 and PNA1-QM1 self adduct inhibited the activity of telomerase 




could be caused by the tight binding between PNA1 and telomerase RNA.94  We did 
not determine whether alkylation of the RNA in telomerase by the self adduct had any 
effects since PNA1 itself binds with RNA and inhibits telomerase activity.  A PNA 
which binds to RNA in telomerase weaker than PNA1 and won’t inhibit the 
telomerase activity itself is necessary to observe the effect of RNA alkylation induced 
by PNA-QM self adduct. 
   
2.2.11 Alkylation of ssDNA by a short PNA2-QMP1 
The Corey group has shown that a PNA with eight bases (5’-CAG TTA GG-3’) 
binds to telomerase RNA but the binding is weaker than the 11-base PNA1 (IC50 = 
0.4 μM vs. 0.01 μM) for inhibition of the telomerase activity.94  Ideally, PNA2 itself 
won’t inhibit the telomerase activity while PNA2-QM self adduct can alkylate RNA 
in telomerase and inhibits telomerase activity.  PNA2 (5’-AEEA-Arg-CAGTTA 
GG-Arg-3’), PNA2-QMP1 and the PNA2-QM1 self-adduct were thereby prepared 
following previously used procedures to prepare PNA1 and PNA1-QMP1 and 
arranged for the inhibition of telomerase activity (Figure 2.15).  Target alkylation of 
RNA in telomerase by PNA2-QM1 self adduct requires the selective binding of 
PNA2 with RNA.  Before alkylating RNA in telomerase, the target delivery of 
QMP1 by PNA2 to its complementary DNA OD1 was first studied to examine the 







Figure 2.15 HPLC purification of crude PNA2 (red) and crude PNA2-QMP1 (black). 
Linear gradient of 10% to 55% aqueous acetonitrile with 0.1% trifluoroacetic acid 
(TFA) at 1 ml/min over 30 minutes. 12 – 14 minutes eluents from crude PNA2 (red) 
and 25 – 28 minutes eluents from crude PNA2-QMP1 (black) were collected. 
 
 
Fig 2.16 A) Alkylation of [32P]-OD1 by PNA2-QM1 self adduct. (A) The self adduct 
was prepared in situ by addition of KF (130 mM) to a solution PNA2-QMP1 (3.3 μM) 
in MES (130 mM pH 7) and NaCl (130 mM) and incubated under ambient conditions 
for 24 h.  The target [32P]-OD1 (3.0 μM) was then added and incubation was 
continued for additional 0 - 4 days.  The products were characterized by 20% 
polyacrylamide denaturing gel. (B) Alkylation of [32P]-OD1 by PNA2-QMP1. 
[32P]-OD1(3.0 μM) was mixed with PNA2-QMP1 (3.3 μM) in solution of NaCl (130 
mM), MES (130 mM, pH 7.0) and KF (130 mM) for 0 - 4 days. (time 0 means 10 – 




Alkylation of OD1 by PNA2-QMP1 and PNA2-QM1 self adduct was used to 
examine the effective binding of DNA by PNA2 (Figure 2.16).  Both PNA2-QMP1 
and PNA2-QM1 self adduct can alkylate target OD1.  Alkylation of OD1 by 
PNA2-QMP1 reached maximum yield at ~70% after two days which is similar to the 
alkylation induced by PNA1-QMP1.  Reducing PNA bases from 11 to 8 doesn’t 
affect the alkylation yield and rate.  Although PNA2-QMP1 alkylate OD1 a little 
quicker than PNA2-QM self adduct, the trend is not as obvious as that for 
PNA1-QMP1 and PNA1-QM self adduct.  The alkylation yield and rate by PNA2 
have no difference from PNA1.  PNA2-QM1 alkylated ~60% of OD1 after 4 days 
compared to ~40% alkylation yield of OD1 from PNA1-QMP1 self adduct.  The 
high alkylation yield of OD1 by PNA1-QM1 self adduct suggests that this self adduct 
might be a good alkylation agent toward RNA in telomerase. 
TRAP assay was used to study the telomerase activity inhibition by PNA2 and 
PNA2-QM1 self adduct.  Preliminary data found that PNA2 itself doesn’t inhibit the 
telomerase activity (Dan Zhang from Prof. Xiang Zhou’s lab, unpublished data).  
While no inhibition of telomerase activity was found after the telomerase was treated 
with PNA2-QM1 self adduct.  One possible reason for this result is that PNA2-QM1 
reacts with RNA in telomerase not quickly enough and might be quenched by other 
nucleophiles.  Novel QMP which can alkylate oligonucleotides faster than QMP1 
may be used to alkylation RNA in telomerase and inhibit telomerase activity.  The 
exact reason why PNA2-QM1 self adduct does not inhibit telomerase is unclear and 




than PNA1 and electron-rich QMP which reacts with RNA quicker than QMP1 may 
be able to inhibit telomerase activity by alkylating RNA in telomerase. 
 
2.2.12 Alkylation of dsDNA by PNA1-QMP1 
Although our initial goal is to recognize single strand oligonucleotide by PNA1, 
use of PNA1 as a directing agent to deliver QMP to dsDNA in vitro and in vivo is 
useful since cellular DNA exists mainly in its duplex form.  Successful alkylation of 
dsDNA requires the co-localization of QMP1 with target dsDNA.  PNA might 
invade into dsDNA and bind with its complementary strand since PNA/DNA binds 
tighter than corresponding DNA/DNA duplex.  It is also obvious that the invasion of 
dsDNA will be easier if the binding site locates at the end of dsDNA than in the 
middle of a duplex.  So two duplex DNAs were chosen as the PNA1-QMP1 
alkylation target.  A 15-base dsDNA1 has the PNA1 binding site at the end of DNA 
and a 56-base dsDNA2 has the same binding site in the middle of dsDNA.  dsDNA 
was then incubated with PNA1-QMP1 and the PNA1-QM1 self adduct to study the 
alkylation of OD1 or OD9 in dsDNA (Scheme 2.12). 
 







dsDNA1 was incubated with PNA1-QM self adduct in 12 - 192 mM NaCl for 4 
days.  Since the melting point of dsDNA increases with higher salt concentration, 
PNA1-QM1 is more difficult to invade into dsDNA at 192 mM NaCl than at 12 mM 
NaCl solution.  After a 4 day incubation, a slow electrophoretic mobility species 
represents the target ssDNA alkylation was found on gel and unexpected, the 
alkylation yields of 25 – 30% were independent of NaCl concentration was used 
(Figure 2.17).  This is because the PNA1 binding site locates at the end of dsDNA 
and the invasion of PNA1 may be less affected by salt concentration as previously 
thought. 
 
Figure 2.17 Alkylation of dsDNA1 by a self adduct.  The PNA1-QM self adduct 
(3.3 µM) and dsDNA1 (3.0 µM) were incubated in MES (12 mM, pH 7.0) and NaCl 
(12 mM – 192 mM) for 4 days. 
 
Both PNA1-QMP1 and PNA1-QM1 self adduct were next incubated with a 56 
bases dsDNA2 in a solution containing 10 mM sodium salt to further study whether 
the location of target sequences within dsDNA has any effect on DNA alkylation 




less than 2% of alkylation (lane 2 - 6), and incubation of this dsDNA with 
PNA1-QM1 self adduct resulted in an alkylation yield of 8.0% (Figure 2.18, lane 11).  
When the salt concentration was increased to 50 mM, less than 2% of the dsDNA2 
was alkylated by PNA1-QM1 self adduct (data not shown).  
 
Figure 2.18 Alkylation of dsDNA2 by PNA1-QMP1 and the PNA1-QM1 self adduct. 
PNA1-QMP1 (3.3 µM) in solution containing 5 mM NaCl and 5 mM NaF was 
incubated with [32P]-OD9 (3.0 µM) for 4 days (lane 1); [32P]-dsDNA2 (3.0 µM) for 0 
– 4 days (lane 2 – 6). PNA1-QMP self adduct (3.3 µM) in buffer containing 10 mM 
NaCl was incubated with [32P]-dsDNA2 (3.0 µM) for 0 – 4 days (lane 7 – 11). 
 
The different of alkylation yield between dsDNA1 and dsDNA2 by 
PNA1-QM1 self adduct (~30% vs. 8.0%) can be explained by the difference of DNA 
invasion ability.  A previous study from Smolina showed that a mixed base PNA can 
induce dsDNA invasion only when the target site is at the end of dsDNA.76  For the 
PNA1-QM1 self adduct, it invades to a lesser extend in dsDNA2 than in dsDNA1 
since the target binding site locates in the middle of dsDNA2.  Other PNA 
sequences which will be studied in the next chapter will be used to recognize dsDNA. 
 
 




2.2.13 Alkylation of plasmid dsDNA by PNA1-QMP1 
Although a mixed sequence of PNA is not expected to invade dsDNA when the 
target sequence is not located at the end of the dsDNA,76 we incubated PNA1-QMP1 
with plasmid DNA containing target sequence because the super coiled structure of 
plasmid DNA can aid invasion of PNA.105, 106 
In order to monitor the target sequence alkylation, we incubated 
[32P]-PNA1-QM1 self adduct with a 3421 bases plasmid DNA – pUC-human 
telomerase RNA (pUC-hTR) containing the target sequence for 4 days under room 
temperature or 37°C. After incubation, the mixture was digested by restriction 
enzyme BsiEI and separated by 2% agarose gel (Figure 2.19).  Each DNA fragment 
band was cut from the agarose gel and measured for 32P by scintillation counting to 
characterize the target DNA alkylation (Figure 2.19).  The restriction fragment 
containing the target DNA was expected to be more strongly radio-labeled since this 
alone should be alkylated.  
After cutting each band from the gel, none of the bands contained radio-activity 
(< 1000 dpm by scintillation counter) compared to > 800,000 dpm radio-active 
[32P]-PNA1-QMP1 used in reaction.  More than 95% of radio-activity corresponding 
to [32P]-PNA1-QMP1 was retained at the loading point of the gel since PNA1-QMP1 
has only one charge and barely moved on gel electrophoresis.  The result showed 





            
Figure 2.19 Agarose gel of BsiEI digested pUC-hTR plasmid DNA. Lane 1: 1 kb 
DNA ladder; lane 2: plasmid DNA digested by BsiEI; lane 3: After plasmid DNA 
was incubated with [32P]-PNA1-QMP1 for 4 days at room temperature, the resulting 
solution was digested by BsiEI; lane 4: After plasmid DNA was incubated with 
[32P]-PNA1-QMP1 for 4 days at 37°C, the resulting solution was digested by BsiEI. 
The PNA1 binding site was indicated in gel. 
   
Lack of dsDNA invasion by PNA1 limits PNA1-QMP1 to localize and alkylate 
target duplex sequences in cells.  Polypyrimidine PNA sequences may be necessary 
to form triplex complexes with dsDNA and potentially deliver QMP to target 
dsDNA.77, 107, 108  Preparation and use of such a polypyrimidine PNAs to deliver 
QMP to target duplex sequences is described in the next chapter. 
 
2.3 Summary 
Delivery of a QMP to target sequences such as ssDNA, ssRNA and dsDNA by 
mixed bases PNAs were studied to evaluate the recognition of oligonucleotides by 




complementary single strand DNAs.  The rates and yields of reaction mimic those 
observed for earlier derivatives based on DNA conjugates.37  PNA1-QMP1 also 
discriminates fully complementary sequences from ones containing T/T or G/T 
mismatch sequences.  The sensitivity toward one base mismatch makes PNA a good 
delivery agent for targeting DNA.  The life time of QM is greatly prolonged by 
forming PNA1-QM1 self adduct compare to the short lived quinone methide.  Even 
after an 8 day incubation under ambient conditions, the self adduct retained more than 
half of its alkylation ability.  The reversible PNA1-QM1 self adducts through 
intrastrand alkylation provides a biocompatible conjugate for delivery of a quinone 
methide for target specific alkylation.  The reversibility of PNA-QM self adduct 
makes it applicable in vivo to alkylate target sequences without the use of toxic 
fluoride.  A random DNA sequence can be held adjacent to PNA1-QMP1 by 
deploying a DNA template.  The random DNA can then be alkylated by QMP1.  
When the random DNA is just adjacent or one base away from PNA1-QMP1, no 
alkylation was observed.  A three extra free bases from target sequence at the 
position close to PNA and the template DNA are required to generate up to 40% 
target alkylation.  
    Since one of our goals is to inhibit telomerase activity by alkylating RNA within 
telomerase, target alkylation of ssRNA which has the same sequence as RNA in 
telomerase was studied.  Target ssRNA was alkylated by either PNA1-QMP1 
conjugate or PNA1-QM1 self adduct successfully.  The inhibition of telomerase 
activity by TRAP assay could not be differentiated from the inhibition induced by the 




than PNA1 was then constructed.  Neither PNA2 nor PNA2-QM1 self adduct 
inhibited telomerase activity.  New PNA which binds to RNA within telomerase 
weaker than PNA1 while stronger than PNA2 may be required to study the effect of 
target RNA alkylation in telomerase.   
The target alkylation was then expanded to dsDNA to study the future 
application in cell environment since DNAs are mainly present in a duplex form in 
cellular conditions.  PNA1-QMP1 and PNA1-QM1 invaded into dsDNA1 in which 
the target sequence is at the end of the duplex DNA.  Salt concentration (12 – 192 
mM) does not affect the DNA invasion and alkylation.  When the target site locates 
in the middle of a 56 bases duplex DNA or a plasmid DNA, no DNA invasion and 
alkylation were found.  These results showed that a target DNA binding or dsDNA 
invasion is requirement to generate target DNA alkylation.  Other deliver methods 
such as the generation of triplex structure are needed to deliver QMP to dsDNA when 
the target locates in the middle of dsDNA. 
 
2.4 Materials and methods 
Materials. Solvents, starting materials, and reagents of the highest commercial grade 
were used without further purification. The pUC-hTR plasmid DNA was provided by 
Prof. Carol Grieder. Single-stranded DNAs and RNA were purchased from IDT 
(Coralville, IA). Aqueous solutions were prepared with distilled, deionized water with 
a resistivity of 18.0 MΩ. Water used in handling RNA was prepared by the laboratory 
of Prof. Sarah Woodson. Boc-protected PNA monomers were obtained from Applied 




mmol/g), boc-protected amino acids, O-(benzotriazol-1-yl)-N, N, N', 
N'-tetramethyluronium hexafluorophosphate (HBTU) and 
2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3- tetramethyluronium hexafluorophosphate 
(HATU) were purchased from Advanced ChemTech (Louisville, KY). 
Boc-8-amino-3,6-dioxaoctanoic acid (Boc-AEEA) was purchased from Peptide 
International (Louisville, KY). Kaiser test kit was obtained from Aldrich (St. Louis, 
MO). T4 polynucleotide kinase (PNK), cAMP-dependent protein kinase (PKA) and 
restriction enzymes were obtained from New England Biolabs (Ipswich, MA). 
[γ-32P]-ATP was purchased from Perkin-Elmer (Waltham, MA). Micro bio-spin 
columns with bio-gel P-6 was from Bio-Rad (Hercules, CA). SepPak C18 cartridge 
was from Waters (Milford, MA). GeneJET plasmid miniprep kit was from Fermentas 
(Glen Burnie, MD). 
PNA Synthesis. PNA-peptide chimera (PNA1, 5’-AEEA-Arg-GTTAGGGTT 
AG-LeuArgArgAlaSerLeuGly-3’) was synthesized on MBHA resin by manual 
solid-phase peptide synthesis as described by Corey group99 and my Master’s 
thesis.109 1.5 mL cleavage solution (1 part thioanisole, 1 part m-cresol, 2 parts 
TFMSA and 6 parts neat TFA) was used to remove the oligomer from 50 mg resin.  
The solution was cooled at -20°C before using.  Freshly opened TFMSA provided 
the best result.109  TFMSA that had turned brown or black provided poor cleavage 
efficiency. 
PNA1 and PNA2 were purified by reverse phase HPLC (RP-HPLC) with a C18 
column (Varian Microsorb-MV, 300Å pore, 250 mm) at 1 ml/min flow rate with a 




30 minutes.. PNA1 was characterized by MALDI-TOF (Shimadzu Axima-CFR) and 
PNA2 was characterized by ESI-MS. PNA1 calculated (m/z) was 4144.6, MALDI 
(m/z) found was 4143.3. [PNA2+3H+]3- calculated (m/z) was 895.3 and ESI-MS (m/z) 
found was 895.2. Calculated [PNA2+2H+]2- was 1342.5 and ESI-MS (m/z) found was 
1342.7 
 
Synthesis of QMP1-NHS ester. 
3-[3-Hydroxymethyl-4-hydroxyphenyl]propionic acid (2.2)97 
Aqueous NaOH (10%, 5 ml) was added to 3-(4-hydroxyphenyl)propionic acid 
(2.0 g, 12 mmol) and pH of the solution was adjusted to 8.  Formaldehyde (37%, 5 
mL) was added to the resulting solution and stirred at 50° C for 17 hours. The yellow 
solution was poured into 100 ml acetone.  The orange oil was collected from the 
bottom of the flask.  The oil was then mixed with 5 ml methanol and poured into 
150 ml acetone to form a white precipitate.  The solid was collected by filtration. 
The solid was then dissolved in 10 ml water and adjusted to pH 3 with 1 M HCl. 
The aqueous solution was extracted with 50 ml ether 3 times.  After the removal of 
ether by rotoevaporator, the remaining liquid was purified by chromatotron (hexane : 
ethyl acetate = 2 : 1 and 0.5% HOAc) and yielded product 2.2 as a faint yellow solid 
(500 mg, 21.2%).  1H NMR (D2O) δ 7.04 (s, 1H), 6.96 (s, H), 6.72 (s, H), 4.48 (s, 
2H), 2.72 (t, J=8, 2H), 2.52 (d, J=8, 2H).  The 1H NMR is consistent with the 
literature.37  
3-[3-tert-Butyldimethylsilyloxymethyl-4-tert-butyldimethylsilyloxyphenyl] 




Imidazole (1.0 g, 15 mmol) was added to a solution of tert-butyldimethylsilyl 
chloride (TBDMSCl, 1.50 g, 10 mmol) and compound 2.2 (500 mg, 2.55 mmol) in 12 
ml of DMF.  The mixture was stirred at room temperature for 15 hours, diluted with 
brine (100 mL), and extracted with 200 mL ether for 3 times.  The organic phases 
were combined, dried over MgSO4, and concentrated under reduced pressure.  The 
product was redissolved in 10 ml MeOH and 1.50 g of potassium carbonate was 
added to the methanol solution.  The solution was stirred for 3 h and adjusted with 
0.2 M HCl to pH = 3.  The mixture was then diluted with water and extracted with 
100 ml ether for 3 times.  The organic phases were combined, washed with brine, 
dried over MgSO4, and concentrated under reduced pressure.  The residue was 
purified by silica gel chromatotron (hexane: ethyl acetate= 19:1) to yield 2.3 as a 
colorless oil (400 mg, 37%).  1H NMR (CDCl3) δ 7.26 (s, 1H), 6.93 (d, J= 8.0, 1H), 
6.65 (d, J= 8.0, 1H), 4.17 (s, 2H), 2.87 (t, J= 8.0, 2H), 2.63 (t, J= 8.0, 2H), 0.98 (s, 
9H), 0.18 (s, 6H).  The 1H NMR is consistent with the literature37 
3-[3-Acetoxymethyl-4-tert-butyldimethylsilyloxyphenyl] propionic acid (2.4)42 
Solid ferric chloride (10 mg, 0.62 mmol) was added to a solution of 2.3 (200 mg, 
0.83 mmol) in acetic anhydride (3 mL) at 0 °C.  The reaction mixture was stirred for 
30 minutes and then extracted with 150 mL ether three times.  The organic phases 
were combined, washed with water and saturated aqueous NaHCO3, dried with 
MgSO4, and concentrated under reduced pressure.  The residue was subjected to 
silica gel flash chromatography (hexane: ethyl acetate= 10:1) and yielded 2.4 as a 




6.74 (d, J= 8.0, 1H), 5.06 (s, 2H), 2.87 (t, J= 8.0, 2H), 2.63 (t, J= 8.0, 2H), 0.97 (s, 
9H), 0.21 (s, 6H).  The 1H NMR is consistent with the literature.37 
N-Succinimidyl-3-(3-acetoxymethyl-4-tert-butyldimethylsilyloxyphenyl) 
propionate (QMP1-NHS ester)37 
N-Hydroxysuccinimide (46 mg, 0.42 mmol) was added to a DMF solution (5.0 
mL) of 2.4 (40 mg, 0.11 mmol).  This mixture was cooled to 0 °C and combined 
with 1-ethyl-3-(3’-dimethylaminopropyl)carbodiimide (EDCI, 80 mg, 0.42 mmol). 
The resulting yellow solution was then stirred for 20 hours from 4 °C to room 
temperature, diluted with brine, and extracted with 30 mL ether for 3 times.  The 
organic phases were combined and washed with brine, dried over MgSO4, and 
concentrated under reduced pressure.  The resulting residue was subjected to silica 
gel flash chromatography (hexane: ethyl acetate, 3:1) to yield QMP1-NHS as a white 
solid (24 mg, 47%).  1H NMR (CDCl3) δ 7.14 (s, 1H), 7.05 (d, J= 8.0, 1H), 6.75 (d, 
J= 8.0, 1H), 5.07 (s, 2H), 2.97 (t, J= 8.0, 2H), 2.88 (t, J= 8.0, 2H), 2.82 (s, 4H), 2.08 
(s, 3H), 0.97 (s, 9H), 0.21 (s, 6H).  1H NMR is consistent with the literature37 
   
Preparation of PNA and QMP1 conjugate (PNA1-QMP1, PNA2-QMP1). 
QMP1-NHS (1 mg) in 100 µl CH3CN/DMF (v/v = 2/1) was mixed with PNA1
 or 
PNA2 (100 µl, 5.0 mM) in MOPS (250 mM, pH 7.5) and incubated for 24 hours at 
room temperature.  The desired product was purified by RP-HPLC using the same 
condition as that used for purification of PNA1.  PNA1-QMP1 calculated (m/z) was 




was 1007.1 and ESI-MS found (m/z) was 1006.5.  PNA2-QMP1 calculated (m/z) 
was 3018.4 and MALDI (m/z) found was 3018.0. 
 
Preparation of PNA-QM self adducts. PNA1-QMP1 or PNA2-QMP1 (20 µM, 100 
µl) were mixed with 200 µl KF (1.0 M) in MES (25 mM, pH 7.0) at room 
temperature.  After 24 hours, the self adduct was purified by RP-HPLC using the 
same condition used for purification of PNA1.  PNA1-QM1 self adduct calculated 
(m/z) was 4305.8 and MALDI (m/z) found was 4304.7.  PNA2-QM1 self adduct 
calculated (m/z) was 2845.2 and MALDI (m/z) found was 2845.0. 
 
Radio-labeling DNA, RNA and PNA. The 5’ terminus of ssDNA was labeled by T4 
PNA and [γ-32P]ATP.  PNA1-QMP1 was labeled by cAMP-dependent protein 
kinase A (PKA, New England Biolab, Ipswich, MA) and [-32P]-ATP as described 
previously.110  Typically, an aqueous solution of PNA1-QMP1 (1.5 L, 50 M) was 
mixed with PKA (2500 units), BSA (2.5 L, 10 mg/ml), ATP (5 L, 25 µM, 25 Ci) 
and buffer (10 L) containing 50 mM MES (pH 6.9), 10 mM MgCl2, 0.5 mM EDTA 
and 1 mM DTT to total 50 L.  After incubation at 37°C for 30 minutes, the reaction 
was desalted using a SepPak C18 reverse-phase cartridge (Waters, Milford, MA). 
After the labeled PNA conjugate was loaded onto a cartridge, water containing 0.1% 
TFA was used to wash the buffer away.  PNA was retained on the C18 cartridge but 
could be washed from resin by 50% acetonitrile in water (0.1% TFA).  The eluent 






1.0 equivalent of the 5’-[32P]-radio labeled oligonucleotide (3.0 M) and 1.1 
equivalent of its unlabeled complementary DNA (3.3 M) were annealed in a 
solution of MES (20 mM, pH 7) and NaCl (20 mM) in a 1.5 mL centrifuge tube. The 
tube was incubated in 90°C water bath for 5 minutes and was cooled to room 
temperature over more than 3 hours.  The final dsDNA concentration is 3.0 M.  
 
Target alkylation of DNA and RNA. 
ssDNA (3.0 M) or dsDNA (3.0 M) were mixed with PNA1-QMP1 (3.3 M) 
in NaCl (130 mM), MES (130 mM, pH 7.0) and KF (130 mM) for different lengths of 
time.  Identical conditions except for the exclusion of fluoride were used when using 
the self-adduct (3.3 M) to alkylate ssDNA (3.0 M).  Reactions were quenched by 
adding 3 L of formamide (0.05% bromophenol blue and 0.05% xylene cyanol FF in 
formamide) and loaded to the gel directly.  Products were analyzed by 20% 
denaturing polyacrylamide gel electrophoresis (PAGE) using 7 M urea, 89 mM 
Tris-borate pH 8, and 5 mM EDTA. A temperature of 40 – 45°C was maintained 
during electrophoresis. Gels were visualized by a Molecular Dynimics 
Phosphorimager (Sunnyvale, CA).  The yield was measured by the ratio of 
radio-activity from high molecular weight band over the sum of the radio-activity 
from high molecular weight band and ssDNA band on PAGE.  All the reactions 






Mini-prep for plasmid DNA 
  A single colony in 5 mL LB broth containing ampicillin (50 µg/ml) was gown with 
shaking (250 RPM) at 37°C.  After overnight incubation, the mixture was 
centrifuged at 5000 g for 5 minutes at 4°C.  After the supernant was carefully 
removed, 1 mL resuspension solution (GTE buffer containing RNase A) was added to 
suspend the pellet.  This mixture was mixed by vortex and then transferred to a 1.5 
mL centrifuge tube.  250 L lysis solution (0.2 M NaOH, 1% sodium dodecyl 
sulphate) was added to the tube and the solution was mixed by inverting the tube for 5 
– 6 times.  Finally, 350 L neutralization solution (20 – 50% guanidinium chloride) 
was added and the tube was inverted for another 5 – 6 times.  Solution was 
transferred to a spin column (Fermentas) and was centrifuged at 16100 g for one 
minute.  500 L wash solution (water diluted by ethanol) was then added to the filter 
and centrifuged at 16100 g for one minute.  The flow through was discarded.  
Another 500 L wash solution (water diluted by ethanol) was added to the filter and 
centrifuged at 16100 g for one minute.  The flow through was discarded.  50 L 
water was added to the filter and a new tube was used.  The mixture was then 
centrifuged at 16100 g for another 2 minutes and the flow through in new tube was 









Chapter 3 Alkylation of double strand DNA by PNA-QMP conjugates 
 
3.1 Introduction 
DNA is typically found as a duplex of anti-parallel strands in nature.  Target 
alkylation of duplex DNA (dsDNA) may inhibit the DNA replication and kill tumor 
cells.  In chapter two, mixed bases PNA designed to alkylation single strand DNA 
(ssDNA) can alkylate dsDNA but only when the target site locates at the end of a 
dsDNA.  This requirement restricts the utility of PNA in delivering alkylation agents 
like QMP to target duplex sequences in vivo.  Oligonucleotides which can recognize 
dsDNA are instead necessary to deliver DNA alkylation agents to target sequences.  
A polypyrimidine oligonucleotide can bind to a polypurine strand of DNA in 
the major groove of dsDNA and form triplex.58  Triplex forming oligonucleotides 
(TFOs) have been used to deliver DNA modification agents such as transplatin,61, 62 
N-mustard79 and psoralen50, 52, 80 to dsDNA.  Results showed that site-specific gene 
modification occurred near target binding sites.  Although the target sequences are 
restricted to polypurine/polypyrimidine, these sequences are not rare in mammalian 
genomes.111, 112  
Seidman studied the use of DNA as a TFO to deliver a psoralen to the Chinese 
hamster ovary (CHO) cell lines (Figure 3.1).113  The hypoxanthine phosphoribosyl 
transferase (Hprt) gene in CHO cells contains a polypurine:polypyrimidine sequence 
adjacent to exon 5 that can serve as a TFO binding site.114  A seventeen base TFO 
can bind with its target dsDNA (Figure 3.1) and psoralen-TFO conjugate induced 





Figure 3.1 Sequences of the triplex target in the CHO Hprt gene and the 
TFO-psoralen conjugate (pso = psoralen) 
 
DNA as a TFO has its limitations.  Normally, magnesium must be present to 
relieve the electron repulsion between a TFO and its target dsDNA.  A pH lower 
than 5.0 and TFOs of more than fifteen bases are required to form stable triplex 
structure.58, 116  PNA is a good replacement of DNA as a TFO.  Ten to fifteen bases 
of polypyrimidine PNA can form triplex structure with target dsDNA since the 
backbone of PNA is neutral and lack of electron repulsion.108  However, a 
PNA·DNA2 triplex is a kinetic product and will be converted to a PNA2·DNA to form 
triplex invasion structures (Scheme 3.1).107, 108  Unlike mixed-bases PNA of chapter 
two, triplex invasion by polypyrimidine PNA can occur in the middle of a dsDNA.  
Thus polypyrimidine PNA is more applicable than mixed-bases PNA in targeting 





Scheme 3.1 Structures of triplex and triplex invasion by polypyrimidine PNA (blue) 
and dsDNA (black) 
   
3.2 Result and Discussion 
3.2.1 Selection of polypyrimidine sequences 
Psoralen-TFO has shown to modify Hprt and induce gene knock in effect.115  
Target delivery of a QMP to Hprt gene by forming PNA·DNA2 triplex will help to 
understand the recognition of dsDNA by polypyrimidine PNA.  We decided to 
synthesize a 14 bases PNA3 (5’-AEEA-Arg-TTCTTTTTTCTCTT 
-LeuArgArgAlaSerLeuGly-3’) containing three arginines to deliver QMP to a target 
dsDNA OD10-OD11 from Hprt gene (Scheme 3.2).  The introduction of three 
positive charges (lysine or arginine) at either end of PNA has a ~14-fold affinity 
improvement in triplex formation.108  Since lysine has an additional free amine 
group at its side chain, the amine group would interfere with the coupling of PNA 
with QMP-NHS ester, arginine was used.  Three arginines within PNA3 will render 




conditions and avoid the reaction with QMP-NHS ester.  AEEA at 5’ terminus of 
PNA aids the conjugation of QMP-NHS ester with PNA3 (chapter 2).  
 
Scheme 3.2 Sequences of PNA3 and its binding sequences in Hprt gene OD10 and 
OD11 
 
3.2.1 Preparation of PNA3-QMP1 and PNA3-QM self adduct 
PNA3 was synthesized by manual solid phase peptide synthesis following the 
standard procedure used in chapter 2.97  The PNA3-QMP1 and PNA3-QM1 self 






























































Scheme 3.3 Generation of PNA3-QMP1 and PNA3-QM1 self adduct 
 
3.2.2 Stability of PNA3-QMP1 in aqueous solution 
PNA-QMP will generate irreversible water adducts and lose its alkylation ability.  
To determine the storage conditions for PNA-QMP conjugates, the stability of PNA3, 




RP-HPLC (Figure 3.2).  PNA3 remained intact after storage at -20°C for three 
months as evident from its homogeneity on RP-HPLC (Figure 3.2, A).  Less than 
5% of PNA3-QMP1 decomposed after three days storage at -20°C.  Materials eluted 
at 19 minute represents intermediate that lost TBDMS protecting group (Figure 3.2, 
B).  The PNA3-QM1 self adduct was also stable after storage at -20°C for one 
month as one peak on HPLC (Figure 3.2, C).  Interestingly, more than 90% of 
HPLC purified PNA3-QMP1 decomposed after approximately three months storage 
at -20°C (Figure 3.2, D).  Peak at 19.2 minutes corresponding to the PNA3-QM1 
intermediate without TBDMS protecting group was shown on HPLC.  Less than 
10% of PNA3-QMP1 remained intact.  Previously, HPLC showed that more than 
80% of a mixed base PNA1-QMP1 conjugate was stable in aqueous solution even 
after eight months storage at -20°C.  The decomposition of PNA3-QMP1 is quicker 
than the mixed base PNA1-QMP1.  It is unclear why PNA3-QMP1 is more prone to 
decompose.  PNA3-QMP1 from different preparations was characterized by HPLC 
to rule out the possibility that there were some impurities in the original PNA3-QMP1 
solution which may catalyze the decomposition of PNA3-QMP1.  The same results 
were found again, almost all PNA3-QMP1 conjugated decomposed.  The result 
showed that PNA3-QMP1 decompose spontaneously but slowly.  The conjugate 






Figure 3.2 HPLC characterization of PNA3, PNA3-QMP1, PNA3-QM self adduct 
and aged PNA3-QMP1. (A) HPLC purified PNA3 was stored at -20°C for three 
months; (B) HPLC purified PNA3-QMP1 aqueous solution was stored at -20°C for 
three days; (C) HPLC purified PNA3-QM1 self adduct was stored at -20°C for one 
month; (D) HPLC purified PNA3-QMP1 aqueous solution was stored at -20°C for 
three months.  All HPLC runs used the same condition: linear gradient of 10% to 







3.2.3 Denaturing of PNA/DNA duplex  
Our ultimate goal was to use the PNA3-QM1 self adduct to alkylate target 
dsDNA by forming triplex structures in cell.  As mentioned in chapter two, 
successful denaturing of PNA/DNA duplexes is necessary to differentiate 
non-covalently bound PNA/DNA from covalently bound PNA-QM-DNA.  
Un-denatured PNA/DNA would have the similar electrophoretic mobility as 
PNA-QM-DNA.  Soon after we prepared PNA3, we found that the PNA3/OD10 
duplex could not be denatured on gel.  Low mobility species were showed when 
OD10-OD11 was incubated with PNA3 in the absence of QMP1.  Nielsen showed 
that the Tm of a 10 base polypyrimidine PNA/DNA duplex was more than 70°C and 
increased approximately 10°C for every additional polypyrimidine base.117  The 
PNA3/OD10 mixture was pre-heated to either 70°C or 90°C for 2 minutes before 
loading onto a denaturing gel, but the low mobility bands representing PNA/DNA 
duplex were still found after electrophoresis.  
  To further address the problem, we used single strand OD12 instead of OD10 
to study the denaturing of PNA/DNA (Scheme 3.4).  The number of triplex forming 
bases in OD12 was 11 as compared to 14 bases in OD10 to reduce the triplex binding 
affinity.  Since dG N7 is a primary alkylation site by QMP,63 several 
deoxyguanosines were placed at both ends of triplex binding site in OD12 to facilitate 






Scheme 3.4 Possible triplex structure of PNA3/OD12 complex. “Dot” means 
Hoogsteen bond and “vertical line” means Watson-Crick bond 
PNA3 was then incubated with [32P]-OD12 to study the conditions for 
successful denaturing.  Theoretically, PNA3 can form both a PNA3/OD12 duplex 
and a PNA3/OD12/PNA3 triplex structure (Scheme 3.4).  After [32P]-OD12 (3.0 μM) 
was mixed with PNA3 (3.3 μM) for 3 days, products were characterized by 20% 
denaturing gel.  The PNA3/OD12 duplex was not fully denatured by denaturing gel.  
When the final solution was pre-heated at 90°C for 2 minutes, still more than 50% of 
high molecular weight band representing non-denatured PNA/DNA duplex was 
observed after gel electrophoresis.   
Phenol-chloroform extraction was next tested to solve the denaturing problem. 
PNA functions like a protein because its neutral amide backbone74 and PNA will be 
extracted by phenol-chloroform.  Phenol extraction was performed 2 - 4 times to 
fully remove PNA from PNA/DNA complexes.  The aqueous solution was finally 
dried by Speed-Vac.  Results were inconsistent.  Sometimes, the PNA/DNA could 
was denatured, no low mobility bands were found after gel electrophoresis.  
Sometimes, low mobility bands representing un-denatured PNA/DNA complexes 
were found after gel electrophoresis.  
A competition experiment was then performed to aid the denaturing of 




might compete with [32P]-OD12 to generate PNA3/OD12 duplex and displace 
[32P]-OD12 into the solution thus aid the denaturing of PNA3/[32P]-OD12 duplex.  
Displacement of [32P]-OD12 was characterized by gel electrophoresis (Figure 3.3).  
After [32P]-OD12 was mixed with PNA3 for 24 hours, 0 – 200 equivalents of 
non-radio labeled OD12 was added to the solution and incubated for another 2 days.   
 
Figure 3.3 Competition-aided DNA denaturation. [32P]-OD12 (50 nM) was incubated 
with PNA3 (3.0 μM) in solution containing 10 mM sodium chloride at room 
temperature for 24 hours.  Various amounts of OD12 were added and the solution 
was incubated for two additional days. Each 5 μL of final solution was then mixed 
with 5 μL of formamide and pre-heated before loading onto the 20% denaturing gel. 
(A) pre-heat at 60°C for 5 minutes; (B) pre-heat at 90°C for 2 minutes. 
 
Almost all the [32P]-OD12 still bound to PNA3 after heating at 60°C with 200 eq. 
of OD12 competitor for 5 minutes (Figure 3.3, A).  Low mobility species 
representing PNA3/[32P]-OD12 duplex remained at ~30% by denaturing gel even 
after 2 minutes pre-heating at 90°C (Figure 3.5, B).  This shows that once a 
PNA/DNA duplex forms, it is stable at even 90°C.  
     Because the alkylation of dG N7 site is labile to piperidine treatment and 
induce strand scission at alkylation site, piperidine treatment was used as an 




be used to monitor the occurrence of DNA alkylation.  After [32P]-OD12 (50 nM) 
was incubated with PNA3-QMP1 (3.0 μM) and fluoride for 24 hours, the mixture was 
subjected to piperidine treatment (Scheme 3.5, Figure 3.4).  
 
Scheme 3.5 Possible alkylation sites for PNA3-QMP1 if PNA2/DNA structure 
formed. 
 
Five minutes incubation at 60°C is enough for A+G foot-printing of ssDNA 
(Figure 3.4, lane 1).  Fifteen to thirty minutes incubation used in the same protocol 
caused over reaction as evident by the disappearance of stating material ([32P]-OD12) 
on gel (Figure 3.4, lane 2 - 4).118  When PNA3 was incubated with [32P]-OD12, no 
cleavage by piperidine treatment was detected on gel (Figure 3.4, lane 6).  More 
than 90% of PNA/OD12 duplex remained non-denatured after 30 minutes incubation 
at 90°C as evident by a slow mobility species detected after electrophoresis.  This is 
consistent with the conclusions that either no alkylation occurred or PNA/DNA 
duplex can not be denatured under these conditions.  When the mixture of OD12 and 
PNA3-QMP1 was treated with piperidine, three fragments were observed and 
corresponded to 25’, 23’ and 21’ on OD12 (Figure 3.4, lane 8).  Although only 
single strand OD12 and PNA3-QMP1 were incubated, a triplex PNA/DNA/PNA 
structure can still be formed (Scheme 3.5).  After formation of triplex, PNA3-QMP1 
alkylated three deoxyguanosines adjunct to one terminus of triplex binding site.  




to OD12 in an anti-parallel manner.  Because the possible DNA fragments from 38’ 
and 40’ alkylation and piperidine treatment will still bind with PNA3, the PNA-DNA 
fragments had similar electrophoretic mobility as non-denatured PNA/DNA duplex 
(HMW bands in Figure 3.6).  These data showed that PNA3/OD12 can’t be 
denatured on gel and piperidine treatment can be used to characterize the target 
alkylation of OD12 by PNA3-QMP1 conjugate.  PNA3 can bind to single strand 
OD12 in a PNA2·DNA manner and deliver QM to OD12. 
 
Figure 3.4 Characterization of DNA alkylation by piperidine cleavage. OD12 A+G 
standard (lane 1 – 4).  Samples were incubated with formic acid at 60°C for 
different times before piperdine cleavage: 5 minutes (lane 1); 15 minutes (lane 2); 
35 minutes (lane 3); 30 minutes (lane 4); after [32P]-OD12 (100 nM) was incubated 
with PNA3 (3.3 μM) in NaHPO4 (20 mM, pH 6.5) and NaF (5 mM) for 3 days, 
samples were either loaded onto the gel directly (lane 5) or treated with piperidine 
before loading onto the gel (lane 6); [32P]-OD12 (100 nM) was incubated with 
PNA3-QMP1 (3.3 μM) in NaHPO4 (20 mM, pH 6.5) and NaF (5 mM) for 1 day. 
This sample was either loaded onto the gel directly (lane 7) or treated with 




3.2.4 Alkylation of dsDNA by PNA3-QMP1 and the PNA3-QM1 self adduct 
Our goal is to selectively deliver QMP1 to the major groove of polypurine and 
polypyrimidine dsDNA by forming PNA/DNA2 triplex.  The only method to 
characterize the alkylation of target ssDNA by PNA3-QMP1 is piperidine treatment.   
We then used piperidine treatment to study the alkylation of dsDNA 
([32P]-OD12-OD13) by PNA3-QMP1 or PNA3-QM1 self adduct.  After dsDNA was 
incubated with PNA3-QMP1 or PNA3-QM1 self adduct for 3 days, samples were 
subjected to piperidine treatment.  More than 90% of the radio-activity was retained 
at high molecular weight band corresponding to the non-denatured PNA/DNA duplex 
and no DNA cleavage was found on gel after piperidine treatment.  Experiments 
were repeated several times and similar results were found (gel not shown).  
One reason that alkylation of dsDNA failed could be the lack of PNA binding to 
dsDNA.  Finding out whether target binding occurred will help the designing of 
future experiments.  If PNA/DNA/DNA triplex forms, PNA will continue to 
generate a triplex invasion product (Scheme 3.1) and displace part of the 
polypyrimidine DNA strand from duplex (Scheme 3.6, OD13).  We used 
permanganate foot-printing to study the triplex invasion by PNA (Scheme 3.6, 
Figure 3.5).  When there is no triplex invasion, thymine in duplex DNA are not 
susceptible to KMnO4 and no strand break can be found on gel.  If triplex invasion 
occurs, thymine from the polypyrimidine strand DNA will be displaced from duplex 
and accessible to KMnO4.  Piperidine treatment will then induce strand break at the 
oxidized thymine.119  The displaced sequence from polypyrimidine DNA can be 




5'-QMP-AEEA-Arg-TT CTT TTT TCT CTT-LRRASLG-C(O)NH2
PNA3-QMP1
5'- TAC CTA ACC CTA ACC AGT ACG CGC GAA GAA AAA AGA AGC GAG ATC GAT ATG CGC TCA AGC -3'
3'-~~ T CTT TTT TCT T-~~QMP-5'
TGC GCG CTT CTT TTT TCT TCG CTC TAG
displaced strand in OD13 by triplex invasion is
liable to KMnO4 foot printing
OD12
OD13
3'- ATG GAT TGG GAT TGG TCA CTA TAC GCG AGT TCG-[32P]-5'
triplex invasion
 
Scheme 3.6 Strand displacement by triplex invasion 
 
Figure 3.5 KMnO4 probing of triplex invasion by PNA3-QMP1 and PNA3.  
OD12-[32P]-OD13 was subjected to KMnO4 probing (lane 1); [
32P]-OD13-OD12 (50 
nM) was incubated with PNA3-QMP1 (1.5 μM) in NaHPO4 (10 mM, pH 6.5) and 
NaF (5 mM) for 1 day, the solution was then subjected to KMnO4 probing (lane 2); 
[32P]-OD13-OD12 (50 nM) was incubated with PNA3 (1.5 μM) in buffer containing 
NaHPO4 (10 mM, pH = 6.5) and NaF (5 mM) for 1 day and then treated with KMnO4 
probing (lane 3); [32P]-OD13 A+G standard (lane 4). 
   
Thymine residues were not susceptible to KMnO4 oxidation in the absence of 
PNA suggesting that all thymines were held within the duplex (Figure 3.5, lane 1).  




incubated with 30 eq. of PNA3-QMP1 or PNA3, (Figure 3.5, lane 2 & 3).  This 
means both PNA3-QMP1 and PNA3 can invade dsDNA.  
Since strand displacement was detected, triplex binding must have occurred.  
The lack of alkylation of dsDNA by PNA3-QMP1 may be from others reasons.  The 
low alkylation yield was difficult to detect after piperidine treatment may contribute 
to the failure of dsDNA alkylation detection.  If triplex invasion can be inhibited 
while only triplex was formed, the PNA·DNA2 triplex might be successfully 
denatured by gel and piperidine treatment might be avoided.  Low alkylation yield 
might be visualized on gel.  
 
3.2.5 Inhibition of triplex invasion by increasing the salt concentrations 
High salt concentration may inhibit triplex invasion since the Tm of duplex 
DNA increases with higher salt concentration while the Tm of PNA/DNA duplex is 
barely affected.74  Since both the formation of triplex and triplex invasion might be 
affected by high salt concentration, maximizing the formation of triplex while 
inhibiting triplex invasion is preferred.  OD15-OD16 containing a 14 base triplex 
recognition site was used.  PNA3 and the PNA3-QM1 self adduct were incubated 
with [32P]-OD15-OD16 under salt concentrations of 15 – 500 mM to study dsDNA 





Scheme 3.7 Triplex invasion by PNA3-QM1. 
 
 
Figure 3.6 Inhibition of DNA invasion by various salt concentrations. 
[32P]-OD15-OD16 duplex (50 nM) was incubated with PNA3 (3.0 μM) or 
PNA3-QM1 (3.0 μM) with 15 or 500 mM NaCl for 2 days under room temperature. 
Sample from lane 1 - 4 were loaded onto gel directly.  Samples from lane 5 and lane 
6 were pre-heated at 90°C for 20 minutes without formamide prior to loading onto gel 
 
As shown on lane 1 and lane 4, when the salt concentration is low (15 mM 
sodium), no free [32P]-OD15 was seen by gel.  All the radio-activity was retained at 
the low mobility species representing the PNA3/OD15 complex.  The result showed 
that both PNA3 and the PNA3-QM self adduct can form triplex invasion.  Once the 




lane 1 and 4 compared with other lanes was due to the precipitation of [32P]-OD15.  
On the contrary, no high molecular weight bands corresponding to PNA/DNA duplex 
persisted in the denaturing gel when samples were incubated with 500 mM salt 
concentration (Figure 3.6, lane 2 and 3).  The high salt concentration (500 mM) 
inhibits the DNA invasion and no PNA3/OD15 duplex was formed.  It is unknown 
whether the PNA/DNA/DNA triplex was formed at lane 2 and 3 prior to gel analysis.  
Even if the triplex forms, it will dissociate under the denaturing conditions of this gel 
electrophoresis experiment.  
We also incubated dsDNA and the PNA3-QM1 self adduct in solution 
containing 500 mM NaCl to investigate the alkylation of dsDNA.  Since the 
non-covalent denaturation is possible under these conditions, low mobility species on 
gel would be DNA alkylation product.  After a 3 day incubation, no low mobility 
band representing DNA alkylation product was observed (Figure 3.6, lane 3).  
Additionally, no evidence of alkylation was detected after piperidine treatment (gel 
not shown).  This unexpected result might be due to the failure of generating stable 
triplex under high salt concentration (500 mM NaCl).  Nielsen showed that 
formation of PNA/DNA/DNA triplex can be partially inhibited by 500 mM – 1M salt 
concentration.107  
 
3.2.6 Alkylation of DNA with eight bases complementary to PNA3. 
Previous experiments showed that neither 11 (PNA3/OD12) nor 10 bases 
complementary (PNA3/OD15) duplex can be denatured on gel.  Failure of 




Although piperidine treatment can be used to characterize the target alkylation, it 
can’t characterize alkylation when the alkylation yield is low or the adduct can be 
reversed by piperidine.  A DNA which can form duplex with PNA3 and the duplex 
can be denatured by gel was necessary before alkylation could be detected.  We 
deployed OD14 which has eight bases complementary to PNA3 and studied the 
denaturing of PNA3/OD14 duplex (Scheme 3.8, Figure 3.7, lane 1).  This 
PNA3/OD14 duplex was successfully denatured by 20% denaturing gel.   
 
Scheme 3.8 Sequences of PNA3 and OD14 
 
Figure 3.7 Alkylation of OD14 by PNA3-QMP1 and PNA3-QM1 self adduct at 
room temperature. All the reactions contained [32P]-OD14 (3.0 μM) in MES (130 
mM, pH 7.0). Lane 1: PNA3 (3.3 μM) in buffer for 7 days; lane 2: HPLC purified 
PNA3-QM self adduct (3.3 μM) in buffer for 7 days; lane 3: PNA3-QMP1 (stored 
under -20°C for 3 months, 3.3 μM) and NaF (130 mM) in buffer for 7 days; lane 4: 
HPLC purified PNA3-QM1 self adduct (3.3 μM) in buffer for 3 days; lane 5: 
PNA3-QMP1 (stored under -20°C for 3 months, 3.3 μM) in buffer for 3 days, no 
NaF was added; lane 6: PNA3-QMP1 (stored under -20°C for 3 months, 3.3 μM) 




Successful denaturing of PNA3/OD14 during gel electrophoresis makes the 
direct detection of OD14 alkylation possible (Figure 3.7).  The PNA3-QM1 self 
adduct can effectively alkylate target OD14 with a yield of ~20% after three days 
(Figure 3.7, lane 2 & 4).  Although most of PNA3-QMP1 lost its TBDMS group 
after its storage at -20°C for three months (Figure 3.2), the resting mixture still 
alkylated target sequence OD14 with a yield of more than 50%.  This yield is similar 
to that produced by alkylation of ssDNA with a mixed base PNA1-QMP1 (~60%).  
Interestingly, no difference in the alkylation yield was detected if fluoride was present 
or absent (Figure 3.7, lane 5 & 6).  Multiple slow mobility bands were detected on 
gel.  This suggests that PNA3 may form a PNA3/OD14/PNA3 triplex and the QMP1 
can be delivered by both PNA3 strands to alkylate OD14.   
  To fully identify the relationship between target alkylation and the formation 
of triplex structure, we studied the alkylation of [32P]-OD14 by PNA3-QM1 self 
adduct.  The PNA3-QM1 self adduct can alkylate up to 20% target ssDNA after 72 – 
96 hours (Figure 3.8).  PNA3-QM1 self adduct produces multiple bands with OD14 






Figure 3.8 Alkylation of [32P]-OD14 by the PNA3-QM1 self adduct. C1: [32P]-OD14; 
C2: [32P]-OD14 (3.0 μM) was incubated with PNA3 (3.3 μM) in NaCl (130 mM), 
MES (130 mM, pH 7.0) and NaF (130 mM) for 96 hours; other lanes: After 
PNA3-QMP1 (3.3 μM) was incubated in NaCl (130 mM), MES (130 mM, pH 7.0) 
and NaF (130 mM) for 24 hours, [32P]-OD14 (3 μM) was added and incubated for 
additional 0 - 96 hours 
   
3.2.7 Generation of PNAs with 8 and 9 base complementarity to their targets 
The results above with OD14 demonstrated that an 8 base oligonucleotide 
complementary to PNA3 was alkylated by PNA3-QM1 self adduct.  The PNA/DNA 
complex was successfully denatured by gel so that the alkylation could be detected.  
PNA4 and PNA5 have an eight polypyrimidine bases were prepared to deliver a QMP 
to target dsDNA (Scheme 3.9).  PNA4 can form a triplex with OD10-OD11.  Since 
PNA4 is 7 bases complementary to OD10, the PNA4/OD10 duplex should be 
denatured on gel.  The non-covalently bound PNA4/OD10 was expected to undergo 
denaturation and target DNA alkylation can be easily detected by gel without the 





Scheme 3.9 Sequences of PNA4, PNA5 and OD10, OD11 
 
  In chapter one, we introduced the lack of reaction of thymine with QM.  
Since there is only one dC – the potential PNA4-QM1 self adduct formation site in 
PNA4, PNA4-QM1 self-adduct greatly changed the integrate structure of PNA4.  
The possible internal loop formed by QM1-AEEA-Arg-TTC of PNA4 could change 
the triplex recognition site from 8 bases TTCTTTTT to 5 bases TTTTT and which 
may compromise recognition of dsDNA.  Previously our group showed that dA can 
effectively capture and release QM intermediate to increase the lifetime of QM.40  
So we also prepared PNA5 which has one extra dA at 5’ terminal of its PNA 
backbone (Scheme 3.10).  Ideally, dA in PNA5 can effectively trap and release the 
QM intermediate and would not affect the binding properties of the original 
polypyrimidine bases. 
 




PNA4 and PNA5 were successfully prepared by solid phase peptide synthesis, 
purified by HPLC and confirmed by mass spectrometry.97  PNA-QMP conjugates 
and PNA-QM self adducts were prepared, purified and characterized following the 
same methods used to prepare the PNA1-QMP1 conjugate and its self adduct (HPLC 
and MS spectrums are shown in Appendix Figure 6 - 15).  
 Both PNA4-QMP1 and PNA5-QMP1 were incubated with OD10-OD11 at 
room temperature to study the target alkylation of dsDNA by PNA-QMP1.  No 
alkylation of DNA was observed by gel electrophoresis although PNA/DNA duplex 
can be denatured on gel.  We suspect that no PNA/dsDNA triplex was formed in 
solution and is consistent with the need for a polypyrimidine PNA longer than 10 
bases to form PNA/dsDNA triplex.108  Shorter PNAs (8 - 10 bases) may require a 
high percentage of cytosine to form PNA/DNA2 triplex.
79  A PNA of 8 bases (PNA4) 
was too short to form a triplex. 
 
3.2.8 Preparation of a cytosine rich PNA (PNA6) and its QMP1 conjugate 
In our attempts to deliver a QM by PNA recognition to a dsDNA, we had three 
major problems: 1) dsDNA probably did not form a triplex with an 8 base recognition 
region of PNA4; 2) PNA/DNA complementary region larger than 10 bases could not 
be denatured for detecting alkylation; 3) A 14 bases dsDNA target may form triplex 
with PNA, but the triplex invasion was continued to be formed, no dsDNA alkylation 
was observed.  To solve these problems, we prepared a new PNA sequence (PNA6) 
and used a different QMP (QMP2) to alkylate target dsDNA.  PNA6 should fulfill 




because it has a 11 base triplex binding site and is a cytosine rich sequence (6 
cytosines); 2) PNA/DNA duplex can be denatured by gel since PNA6 is only 5 bases 
complementary (anti-parallel) to its binding DNA – OD17 (Scheme 3.11).  The 
novel QMP2 was prepared by Chengyun Huang from Rokita group recently as an 
electron-rich QMP2 (Scheme 3.12).120  One carbon attached to the aromatic system 
in QMP1 is substituted by an oxygen atom inQMP2.  The extra oxygen stabilizes the 
QM intermediate and accelerates generation of QM.45   
 
 
Scheme 3.11 Sequences of PNA6, target dsDNA OD17-OD18 and OD19-OD20 
 
 
Scheme 3.12 Structure of QMP1 and QMP2 
Recently, Chengyun Huang demonstrated that the novel DNA-QMP2 conjugate 
and its self adduct can form triplex with a polypurine:polypyrimidine duplex DNA 
target and the alkylation of target sequences was more rapidly than the traditional 




alkylate its target (OD17-OD18 and OD19-OD20) and the adduct should be easily 
characterized by denaturing gel since PNA6 was only 5 bases that are complementary 
to OD17. 
Both PNA6-QMP1, PNA6-QMP2 and their self adducts (Scheme 3.13) were 
prepared following the same methods to generate PNA1-QMP1 and its self adduct.  

























Scheme 3.13 Structures of PNA6-QMP1 and PNA6-QMP2 
 
3.2.9 Alkylation of duplex DNA by PNA6-QMP1 and PNA6-QMP2. 
We chose two duplex DNAs, OD17-OD18 and OD19-OD20 as targets to study 
the target sequence alkylation (Scheme 3.12).  Both dsDNAs have the same 11- 
base recognition site to PNA6.  OD19-OD20 is from the natural NFKB1 gene and 
has an adenine base adjunct to recognition site.  Since guanine N7 was found to be a 
primary alkylation site of QMP1121, the guanine near the triplex binding site may 
boost the yield of DNA alkylation.  Target dsDNA OD17-OD18 has a guanine base 
at the adjunct of PNA6 binding site was also studied (Scheme 3.11).  PNA6-QMP1, 
PNA6-QMP2 and their self adducts were incubated with target [32P]-OD17-OD18 





Figure 3.9 Alkylation of dsDNA by PNA6-QMP1 and PNA6-QMP2 conjugates. 
PNA6 conjugates (5 μM) and dsDNA (50 nM) were incubated in 160 mM NaCl and 
10 mM NaHPO4 (pH 6.0) at 37°C for 4 days except lane 1 and 11 were incubated at 
room temperature for 4 days. 
 
As expected, PNA6/DNA complexes can be denatured by gel analysis (Figure 
3.9, lane 5 & 6).  PNA6-QM1 self adduct did not alkylate target DNA as evident by 
the lack of low mobility products (lane 5, 6, 9 & 10).  Almost no alkylation products 
by PNA6-QMP1 were generated at either room temperature or 37°C (lane 1, 2).  In 
contrast, PNA6-QMP2 provided alkylation bands (Figure 3.9, lane 7, 8).  When a 
guanine is adjacent to the binding site of [32P]-OD17-OD18, [32P]-OD17 was 
alkylated in ~25% yield (Figure 3.9, lane 12 - 13).  Although the PNA6-QM2 self 
adduct can also alkylate [32P]-OD17-OD18, the yield is less than PNA6-QMP2 (11% 
vs 25%, lane 14 vs. lane 12).  Also, unlike the requirement for generating DNA 




backbones as is necessary for DNA·DNA2 triplex.
114  DNA alkylation was 
independent of MgCl2 (lane 12 vs. lane 13).   
Two reasons might explain the higher alkylation yield from QMP2 than QMP1.  
First, generation of QM2 and the alkylation of DNA by QM2 are quicker than QM1.  
The quick generation of PNA6-QM2-DNA adduct will stabilize the triplex structure.  
Secondly, the linker locates at the para- position of TBDMS in QM1 while the link in 
QM2 locates at the meta- position of TBDMS.  Oxygen at the meta- position can 
form resonance structure and stabilize QM2.45 
KMnO4 foot-printing was used to probe the strand displacement after triplex 
invasion (Figure 3.10).  After PNA6-QMP2 (250 nM) was incubated with 
OD17-[32P]-OD18 (50 nM) in buffer at room temperature for 4 days, the mixture was 
subjected to KMnO4 treatment.  The resulting cleavage caused by the displacement 
of thymine from OD18 showed that strand invasion occurred.  Considering PNA6 
has only 5 bases that are complementary to OD17, Tm of 5 bases complementary 
PNA/DNA is not high enough to support triplex invasion.  PNA6 likely generates a 
parallel PNA/DNA duplex with OD17 but not traditional anti-parallel PNA/DNA 






Scheme 3.14 Parallel strand invasion by PNA6-QMP2 
 
Figure 3.10 Foot-printing of displacement of OD18 to check for strand invasion. 
[32P]-OD17 A+G ladder (lane 1); PNA6-QMP2 (0.25 μM) was incubated with 
[32P]-OD17-OD18 (50 nM) in 160 mM NaCl, 10 mM NaHPO4 (pH 6) and NaF (5 
mM) at room temperature for 4 days and then was treated with piperidine (lane 2); 
OD17-[32P]-OD18 (50 nM) was incubated with PNA6-QMP2 (0.25 μM) (lane 3) or 
without PNA6-QMP2 (lane 4) in 160 mM NaCl, 10 mM NaHPO4 (pH 6) and 5 mM 
NaF at room temperature for 4 days, samples were probed by KMnO4 foot-printing; 
KMnO4 treatment of [




3.2.10 Time dependence of dsDNA alkylation by PNA6-QMP2 
The time dependence of PNA6-QMP2 reaction was measured to determine the 
rate of dsDNA alkylation (Figure 3.11).  Neither the PNA6-QM2 self adduct nor 
PNA6-QMP1 alkylated dsDNA (Figure 3.11, lane 1 & 2).  50 equivalent of 
PNA6-QMP2 alkylated dsDNA at 37°C.  48 hours are required to reach a maximum 
alkylation yield of ~27% (Figure 3.11, lane 7).  Multiple slowly migrating species 
were found on denaturing gel suggesting that alkylation may have occurred on several 
alkylation sites (Figure 3.11).  This can be explained by the several binding patterns.  
PNA6-QMP2 and DNA can generate both PNA/DNA2 (triplex) and PNA/DNA/PNA 
(parallel strand invasion) as shown in Scheme 3.14.   
 
Figure 3.11 Alkylation of dsDNA by PNA6-QMP2. [32P]-OD17 (2.2 μM) was 
incubated with PNA6-QMP2 (2.5 μM) in 10 mM sodium phosphate (pH 6), 50 mM 
NaCl and 100 mM NaF at 37°C for 4 days (lane 3). [32P]-OD17-OD18 duplex (50 nM) 
was incubated in same buffer as used in lane 3 at 37°C for 4 days with PNA6-QM2 
self adduct (2.5 μM) (lane 1); PNA6-QMP1 (2.5 μM) (lane 2); PNA6 (2.6 μM) (lane 
4).  [32P]-OD17-OD18 duplex (50 nM) was incubated in buffer at 37°C for 0 - 4 
days with PNA6-QMP2 (2.5 μM) (lane 5 - 13).  Final mixtures were mixed with 





3.2.11 Effect of a single-base mismatch on dsDNA alkylation by PNA6-QMP2 
Selective delivery of QMP2 to target sequences by PNA requires discrimination 
of its target dsDNA effectively from off-target DNAs.  One base mismatch at either 
the end or middle of the binding site on duplex DNA target was used to test the 
specificity of PNA6 (Scheme 3.15).  Both the OD17E-OD18E and OD17M-OD18M 
duplex have the same triplex recognition site as OD17-OD18 except each duplex 
DNA present one C/T or T/T mismatch of Hoogsteen pairing (Figure 3.12).  
 
 
Scheme 3.15 PNA6-QMP2 and the sequences of its targets containing one mismatch 
 
When ssDNA was incubated with PNA6-QMP2 in the presence of fluoride, the 
ssDNA can be alkylated with a yield ranging from 20% to 65% (Figure 3.12B lane 4 
- 6).  Multiple bands generated with excess PNA-QMP suggested that that multiple 
PNA/DNA alkylations could be formed during reaction.  Fully matched OD17 
(parallel match, not complementary) was alkyated with the greatest yield (65%) and 




presence of a mismatch at the end of binding site (OD17E) only slightly decreased the 
alkylation yield (55%).  Although the single strand OD17M could be alkylated by 
PNA6-QMP2, its yield of 20% is significantly lower than that of OD17 (65%).  
These results showed that the place of the mismatch inside the triplex recognition site 
greatly affects the alkylation yield despite the alkylation of all the single strands. 
 
Figure 3.12 Alkylation of ssDNA and dsDNA by PNA6-QMP2. E means OD17E, M 
means OD17M. (A) duplex DNA (50 nM) (lane 1: OD17-OD18; lane 2: 
OD17E-OD18E or lane 3: OD17M-OD18M) was incubated with PNA6 (2.5 μM) in 
buffer (50 mM NaCl, 100 mM NaF and 10 mM NaHPO4 pH 6.0) at 37°C for 3 days. 
(B) ssDNA (0.2 μM) (lane 4: OD17; lane 5: OD17E or lane 6: OD17M) was 
incubated with PNA6-QMP2 (10 μM) in buffer (50 mM NaCl, 100 mM NaF and 10 
mM NaHPO4 pH 6.0) at 37°C for 3 days. (C) duplex DNA (50 nM) (lane 7: 
OD17-OD18; lane 8: OD17E-OD18E or lane 9: OD17M-OD18M) was incubated 
with PNA6-QMP2 (2.5 μM) in buffer (50 mM NaCl, 100 mM NaF and 10 mM 
NaHPO4 pH 6.0) at 37°C for 3 days. 
 
The effect of a single base mismatch is more obvious in alkylation of dsDNA 
than the alkylation of ssDNA by PNA6-QMP2 (lane 7 - 9).  Under conditions that 




compared to a 6% of alkylation yield with a C/T mismatch at the end of triplex 
recognition site (lane 8).  When a mismatch was present in the middle of the triplex 
recognition site, almost no target DNA alkylation was detected (lane 9).  These data 
showed that the third strand PNA6 is very sensitive to its recognition site, even one 
base mismatch greatly surpress the formation of triplex.  The sensitivity of this 
system should make the PNA useful in delivering QMP2 to target sequences in cells 
in the future. 
 
3.3 Summary 
Target alkylation of dsDNA should help the use of PNA-QMP under cell 
conditions in the future.  In a 14 base polypyrimidine PNA sequence containing only 
3 cytosines (PNA3), PNA3-QMP1 conjugates decomposed after eight months at 
-20°C.  Thermodynamically stable triplex invasion products are the final products 
when polypyrimidine PNA was incubated with dsDNA.  Complementary 
polypyridmine PNA/DNA which has more than 8 Watson-Crick bases can not be 
denatured by denaturing conditions used by gel electrophoresis.  When eight to nine 
bases PNA were used to deliver QMP to target dsDNA, no target dsDNA alkylation 
was observed by gel.  The failure of alkylation was possibly due to the poor binding 
of PNA to dsDNA. 
Successful delivery of an electron-rich QMP2 by PNA6 was detected by gel. 
PNA6 contained 11 bases to form Hoogsteen bonds with its target dsDNA and 5 
bases within PNA6 can generate Watson-Crick bonds with the polypurine strand of 




Interestingly, this PNA6 can still invade into dsDNA and form a parallel PNA/DNA 
structure.  Only the electron rich QMP2 conjugated with PNA6 could alkylate 
target dsDNA (~25%).  Traditional QMP1 conjugated with PNA6 showed little 
alkylation (< 10%) toward dsDNA under the same conditions.  The successfully 
alkylation of dsDNA by PNA6-QMP2 could be applied to the cell environment 
where a recognition site exists. 
 
3.4 Materials and methods 
Materials Materials used in this chapter is the same as those used in chapter two.   
QMP2 was synthesized by Chengyun Huang in Rokita lab. 
 
PNA preparation: PNAs were synthesized following standard solid phase peptide 
synthesis techniques described in chapter two.  PNAs were purified by reverse phase 
HPLC (RP-HPLC) with a C18 column (Varian Microsorb-MV, 300Å pore, 250 mm) 
at 1 ml/min flow rate with a gradient of the organic phase increasing from 10% to 
55% in 30 minutes.  PNAs were characterized by MALDI-TOF and ESI-MS (Table 
3.1). 
Name Calculated mass (m/z) Found (m/z) 
PNA3 4755.2   (MALDI) 4753.4 
PNA4 2589.7   (MALDI) 2590.6 
[PNA5+3H+]3+ 956.0    (ESI) 956.2 
PNA6 3469.9   (MALDI) 3471.5 




Preparation of PNA and QMP1 or QMP2 conjugate: Procedures for conjugating 
PNAs and QMPs were the same as those described in chapter two.  Conjugates were 
purified by HPLC and confirmed by MALDI. 
 
Preparation of PNA-QM or PNA-QM2 self adduct: PNA-QMP1 (Table 3.2). 
Procedures were the same as used in chapter two.  The self adducts were purified by 













PNA3-QMP1 5090.7 5091.8 PNA3-QM 4916.4 4918.4 
PNA4-QMP1 2924.2 2925.0 PNA4-QM 2749.9 2747.9 
PNA5-QMP1 3199.5 3198.0 PNA5-QM 3025.2 3024.0 
PNA6-QMP1 3805.4 3805.6 PNA6-QM 3631.1 3630.2 
PNA6-QMP2 3809.4 3808.8 PNA6-yQM 3635.1 3636.3 
Table 3.2 Mass spectral analysis of PNA-QMP conjugates and PNA-QM self adducts 
 
Target alkylation of DNA 
ssDNA (2.2 μM) or dsDNA (50 nM) was mixed with PNA-QMP1 in solution 
of NaCl (50 mM), NaF (100 mM) and NaHPO4 (10 mM, pH 6.0) for the indicated 
time at room temperature.  When ssDNA (2.2 μM) was incubated with PNA-QMP2 
(2.5 μM) under the same buffer conditions mentioned above, reactions were carried 
out at 37°C.  When the self-adduct (3.3 μM) was used to alkylate ssDNA (3.0 μM), 
the reaction contained only NaCl and NaHPO4 (pH 6).  Reaction (5 μL) was stopped 




FF in formamide).  Products were analyzed by 20% denaturing polyacrylamide gel 
electrophoresis (PAGE) using 7 M urea, 89 mM Tris-borate pH 8, and 5 mM EDTA.  
A temperature of 50 – 55°C was maintained during electrophoresis.  Gels were 
visualized by a Molecular Dynimics Phosphorimager (Sunnyvale, CA).  Yield was 
calculated by dividing the radio activity of slow mobility bands with the overall radio 
activity of that line on gel. 
 
Phenol-chloroform extraction 
Reaction samples (5 μL) were diluted to 100 μL by H2O and 100 μL phenol 
extraction solution (phenol/chloroform/isoamyl alcohol = 25/24/1) was added to the 
reaction sample.  The resulting mixture was vortexed for thirty seconds and was 
centrifuged at 16100 g for 5 minutes.  The organic solution (bottom layer) was 
carefully removed by pipette.  After repeating the extraction for 2 – 4 time, the DNA 
in aqueous phase was dried by Speed-Vac and ready for future use. 
 
Piperidine Cleavage118 
    Reaction samples (10 μL) were suspended in 50 μL of 10% v/v piperidine and 
incubated at 90°C for 30 minutes.  After incubation, the samples were dried in a 
Speed-Vac for 30 minutes.  The dried samples were dissolved with 50 μL water and 







KMnO4 Foot printing 
    Reaction samples (10 μL, containing PNA-QMP and dsDNA) in buffer (10 mM 
NaHPO4 pH 6, 10 – 150 mM NaCl, 5 – 100 mM NaF) were mixed with 2 μL KMnO4 
(20 mM) for 1 minute at room temperature, and the reactions were quenched by 
adding 2 μL 2-mercaptoethanol.  The resulting solutions were dried by Speed-Vac 
and subjected to piperidine treatment. 
 
Maxam A+G lane sequencing reaction (DNA A+G ladder) 
    [32P]-DNA (1 μL) and 2 μL calf thymus DNA (1 mg/ml) were mixed with 4 μL 
formic acid (10% v/v) and incubated at 60°C for 10 minutes.  The samples were 
















Chapter 4 Conclusions  
Alkylation of target DNA is essential to improve the drug selectivity in tumor 
cells and reduce their side effects.  Previously, alkylation of target DNA by a 
oligonucleotide – quinone methide precursor (QMP) conjugate and its self adduct was 
achieved in vitro.37  Generally, the requirement of UV, heat or chemicals to initiate 
alkylation restricts the use of DNA alkylating agents in cell environment.  The 
reversibility of the oligonucleotide-QM self adduct supports potentially use in vivo 
since no additional trigger is needed to initiate target alkylation. Oligonucleotides as 
site-directing agents have limitations due to their lack of stability in vivo and cellular 
penetration.   
This dissertation has focused on studying delivery of QMP to single and double 
strand DNA by peptide nucleic acids (PNAs).  PNAs are resist to nucleases in vivo 
and can pass through cellular membrane when conjugated with positive peptides. 
These properties make PNA superior to DNA as delivery agent.  PNA can bind with 
it complementary DNA or RNA with Watson-Crick base pairing rules.  PNA-QM 
self adduct is expected to be reversible since PNA has the same bases as DNA, thus 
PNA could provide in vivo alkylation from a self adduct as DNA had acted in vitro.  
The reversibility, stability and potential cell penetrating ability make PNA a good 
target directing agent to deliver QMP in cells. 
A single strand DNA can be alkylated by PNA-QMP with ~70% alkylation yield 
while no alkylation occurred when PNA-QMP was incubated with off-target 




one base mismatch sequences, the conjugate showed strong selectivity toward its 
complementary sequence. 
To deliver QMP to target DNA in cells, toxic fluoride can’t be used to initiate 
the alkylation.  PNA-QM self adduct can avoid the use of fluoride when the self 
adduct is reversible.  The reversibility of a PNA-QM self adduct was confirmed by 
incubating the self adduct with target single strand DNA.  The self adduct was able 
to alkylate its complementary DNA with a ~40% alkylation yield.  After 7 days 
pre-incubation in aqueous solution, only half of reversible self adduct was quenched 
by irreversible reaction and another half was still able to alkylate its target sequence.   
For the first time, successful target alkylation of RNA by PNA-QMP and its 
self adduct were shown.  Alkylation of RNA makes PNA-QM self adduct 
potentially applicable in alkylating RNA in telomerase and inhibiting telomerase 
activity to kill tumor cells.  TRAP assay showed that both PNA and PNA-QM self 
adduct can inhibit telomerase activity.  Although the inhibition of telomerase 
activity from PNA binding with RNA in telomerase can not be differentiate from 
inhibition induced by RNA alkylation, at least PNA can effectively deliver QMP to a 
target sequence within telomerase. 
Polypyrimidine PNA was also used to deliver QMP to duplex DNA (dsDNA) 
by forming triplex structures.  Ten to fourteen bases polypyrimidine PNAs were 
shown to bind with their target DNA and form triplex.  After the formation of 
PNA·DNA2 triplex, PNAs continue to invade into dsDNA and form triplex invasion 




complementary bases can not be denatured on and the target DNA alkylation can not 
be detected by denaturing gel.   
An eleven base polypyrimidine PNA6 which has six cytosines was able to 
deliver an electron-rich QMP2 to target dsDNA.  The cytosine rich PNA6 showed 
target selectivity toward dsDNA.  A single mismatch in the target dsDNA can totally 
inhibit its alkylation.  The high sensitivity of PNA toward dsDNA makes PNA a 
good directing agent to deliver QMP2 in vivo.   
This dissertation studied the requirements of PNA to successful delivery of 
QMP to target ssDNA, ssRNA and dsDNA.  A mixed base PNA can target ssDNA 
and ssRNA by forming duplex while polypyrimidine PNA is required to form a 
triplex structure for recognition of a target dsDNA.  Furthermore, the requirement of 
an electron-rich QMP2 has been shown in alkylating dsDNA.  From these results, 
corresponding PNA sequences can be designed to target different DNA or RNA.    











Instructions for the following tables: These sheets mark each step of the 
sequence--giving the reagents used and the times required.  Working down a column, 
each block can be checked off as that particular step is completed.  When a column 
is finished, goes to the top of next column. 
resin 100 mg (0.7 mmol/g, 70 µmol) was swelled in DMF for three hours 
3-GlyLeuSerAlaArgArgLeu-PNA-Arg-QMP 
AA monomers G Capping L S A R R L 
95% TFA/ m-cresol (2 
× 4 min) 
× ×       
DCM wash (3 × 0.5 
min) 
× ×       
Kaiser test  ×       
DMF wash (1 × 1 min)  ×       
DCM wash (2 × 0.5 
min) 
 ×       
Coupling (20 min)  Capping        
DMF wash (2 × 1 min)         
DCM wash (2 × 1 min)         
Kaiser test         
Next column         
 




Resin-kemptide 60 mg (0.7 mmol/g, 42 µmol) was swelled in DMF for three hours 
3-GlyLeuSerAlaArgArgLeu-GATTGGGATTG-Arg-AEEA-NH2-5’ 
PNA monomers G Capping A T T G G G G G A T T G
95% TFA/ m-cresol (2 × 
4 min) 
 ×      ×  ×     
DCM wash (2 × 0.5 min)  ×      ×  ×     
NMP wash (1 × 0.5 min)  ×      ×  ×     
DCM wash (2 × 0.5 min)  ×      ×  ×     
Kaiser test  ×        ×     
DMF wash (1 × 1 min)  ×      ×       
DCM wash (2 × 0.5 min)  ×      ×  ×     
Coupling (20 min)  Capping             
DMF wash (2 × 1 min)               
DCM wash (2 × 1 min)               
Kaiser test ×              
Next column               
 
Table 2. Procedures for PNA synthesis.  When a continuous “G” was synthesized, a 









Figure 1. ESI-MS of PNA2. [PNA2+3H+]3- calculated (m/z) was 895.3 and ESI-MS 
(m/z) found was 895.2. Calculated [PNA2+2H+]2- was 1342.5 and ESI-MS (m/z) 





Figure 2. ESI-MS of PNA2. [PNA2-QMP1+3H+]3- calculated (m/z) was 1007.1 and 
ESI-MS found (m/z) was 1006.5.  [PNA2-QMP1+2H+]3- calculated (m/z) was 





Figure 3. HPLC and MALDI spectrum of PNA3. Linear gradient of 10% to 55% 
aqueous acetonitrile with 0.1% trifluoroacetic acid (TFA) at 1 ml/min over 30 
minutes, 16 – 18 minute eluent was collect, lyophilized and characterized by MALDI. 
PNA3 calculated (m/z) is 4755.2 and MALDI found (m/z) was 4755.4 
 
Figure 4. HPLC and MALDI spectrum of PNA3-QMP1. Linear gradient of 10% to 
55% aqueous acetonitrile with 0.1% TFA at 1 ml/min. The 26 - 28 minutes eluents 
from HPLC was collected and examined by MALDI. PNA3-QMP1 calculated (m/z) 





Figure 5. HPLC and MALDI spectrum of PNA3-QM1 self adduct.  Linear gradient 
of 10% to 55% aqueous acetonitrile with 0.1% TFA at 1 ml/min.  The 16 - 20 
minutes eluents from HPLC was collected and examined by MALDI. PNA3-QM1 











Figure 6. HPLC spectrum of PNA4.  Linear gradient of 10% to 55% aqueous 
acetonitrile with 0.1% TFA at 1 ml/min. 
 
Figure 7. MALDI spectrum of PNA4. PNA4 calculated (m/z) is 2589.7 and MALDI 






Figure 8. HPLC spectrum of PNA4-QMP1.  Linear gradient of 10% to 55% 
aqueous acetonitrile with 0.1% TFA at 1 ml/min. 
 
 
Figure 9. MALDI spectrum of PNA4-QMP1. PNA4-QMP1 calculated (m/z) is 









Figure 10. HPLC spectrum of PNA4-QM1 self adduct.  Linear gradient of 10% to 




Figure 11. MALDI spectrum of PNA4-QM1 self adduct.  PNA4-QM1 self adduct 






Figure 12. HPLC spectrum of PNA5.  Linear gradient of 10% to 55% aqueous 
acetonitrile with 0.1% TFA at 1 ml/min. 
 
Figure 13. ESI-MS of PNA5. [PNA5-QMP1+3H+]3- calculated (m/z) was 956.0 and 





Figure 14. HPLC spectrum of PNA5-QMP1.  Linear gradient of 10% to 55% 
aqueous acetonitrile with 0.1% TFA at 1 ml/min. 
 
 
Figure 15. HPLC spectrum of PNA5-QM1 self adduct.  Linear gradient of 10% to 





Figure 16. HPLC spectrum of PNA6.  Linear gradient of 10% to 55% aqueous 
acetonitrile with 0.1% TFA at 1 ml/min. 
 
 
Figure 17. MALDI spectrum of PNA6.  PNA6 calculated (m/z) is 3469.9 and 





Figure 18. HPLC spectrum of PNA6-QMP1.  Linear gradient of 10% to 55% 
aqueous acetonitrile with 0.1% TFA at 1 ml/min. 
 
Figure 19. MALDI spectrum of PNA6-QMP1.  PNA6-QMP1 calculated (m/z) is 






Figure 20. HPLC spectrum of PNA6-QM1 self adduct.  Linear gradient of 10% to 









Figure 21. HPLC spectrum of PNA6-QMP2.  Linear gradient of 10% to 55% 
aqueous acetonitrile with 0.1% TFA at 1 ml/min. 
 
Figure 22. MALDI spectrum of PNA6-QMP2.  PNA6-QMP2 calculated (m/z) is 
3809.4 and MALDI found (m/z) was 3808.8.  PNA6-QM2 self adduct calculated 
(m/z) is 3635.1 and MALDI found (m/z) was 3636.3.  PNA6-QM2 water adduct 





Figure 23. HPLC spectrum of PNA6-QM2 self adduct.  Linear gradient of 10% to 
55% aqueous acetonitrile with 0.1% TFA at 1 ml/min. 
 
Figure 24. MALDI spectrum of PNA6-QM2 self adduct.  PNA6-QM2 self adduct 
calculated (m/z) is 3635.1 and MALDI found (m/z) was 3634.2.  PNA6-QM2 water 
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